|
G |
Aacs |
acetoacetyl-CoA synthetase |
decreases expression |
EXP |
bromobenzene results in decreased expression of AACS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:31,113,098...31,156,411
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
increases expression |
EXP |
bromobenzene results in increased expression of AASS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:51,606,461...51,663,136
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
EXP |
bromobenzene results in increased expression of ABCB1A mRNA |
CTD |
PMID:15976192 |
|
NCBI chr 4:26,312,403...26,488,456
|
|
G |
Abcb7 |
ATP binding cassette subfamily B member 7 |
increases expression |
EXP |
bromobenzene results in increased expression of ABCB7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:69,295,598...69,436,775
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP |
bromobenzene results in increased expression of ABCC3 mRNA |
CTD |
PMID:17538237 |
|
NCBI chr10:79,793,571...79,839,528
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases expression |
EXP |
bromobenzene results in increased expression of ABCC4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:101,948,387...102,182,912
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ABCC8 mRNA |
CTD |
PMID:15976192 |
|
NCBI chr 1:105,734,992...105,816,272
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ABCG2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:89,006,056...89,132,915
|
|
G |
Abhd15 |
abhydrolase domain containing 15 |
increases expression |
EXP |
bromobenzene results in increased expression of ABHD15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:62,363,209...62,368,600
|
|
G |
Ablim3 |
actin binding LIM protein family, member 3 |
increases expression |
EXP |
bromobenzene results in increased expression of ABLIM3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:55,256,135...55,376,629
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACAT2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:50,100,840...50,118,886
|
|
G |
Acer2 |
alkaline ceramidase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of ACER2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:101,391,830...101,442,615
|
|
G |
Ackr2 |
atypical chemokine receptor 2 |
increases expression |
EXP |
bromobenzene results in increased expression of ACKR2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:121,559,563...121,573,633
|
|
G |
Acly |
ATP citrate lyase |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACLY mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:85,412,045...85,464,253
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
increases expression |
EXP |
bromobenzene results in increased expression of ACOT4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:103,668,699...103,674,037
|
|
G |
Acsbg1 |
acyl-CoA synthetase bubblegum family member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ACSBG1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:54,991,294...55,047,276
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACSL1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr16:45,755,246...45,821,541
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACSL3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:80,115,164...80,164,636
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACSS2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:144,003,808...144,047,452
|
|
G |
Actb |
actin, beta |
increases expression |
EXP |
bromobenzene results in increased expression of ACTB mRNA |
CTD |
PMID:16036859 |
|
NCBI chr12:16,776,664...16,779,634
|
|
G |
Actl7b |
actin-like 7b |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACTL7B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:71,445,532...71,446,920
|
|
G |
Actn4 |
actinin alpha 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACTN4 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 1:84,182,783...84,251,867
|
|
G |
Adamts15 |
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
increases expression |
EXP |
bromobenzene results in increased expression of ADAMTS15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:29,307,864...29,331,249
|
|
G |
Adamts3 |
ADAM metallopeptidase with thrombospondin type 1, motif 3 |
increases expression |
EXP |
bromobenzene results in increased expression of ADAMTS3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:18,231,128...18,437,771
|
|
G |
Adamts7 |
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ADAMTS7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:90,704,727...90,744,333
|
|
G |
Adgrf3 |
adhesion G protein-coupled receptor F3 |
increases expression |
EXP |
bromobenzene results in increased expression of ADGRF3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:26,133,176...26,144,601
|
|
G |
Adgrg3 |
adhesion G protein-coupled receptor G3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ADGRG3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:9,972,425...10,001,118
|
|
G |
Adgrg5 |
adhesion G protein-coupled receptor G5 |
increases expression |
EXP |
bromobenzene results in increased expression of ADGRG5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:10,074,787...10,098,640
|
|
G |
Adm2 |
adrenomedullin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of ADM2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:120,393,179...120,394,965
|
|
G |
Adora2b |
adenosine A2B receptor |
decreases expression |
EXP |
bromobenzene results in decreased expression of ADORA2B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:46,940,394...46,956,772
|
|
G |
Adra2c |
adrenoceptor alpha 2C |
decreases expression |
EXP |
bromobenzene results in decreased expression of ADRA2C mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:75,470,884...75,472,846
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression |
EXP |
bromobenzene results in increased expression of AHR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Aim2 |
absent in melanoma 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of AIM2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:88,397,516...88,439,325
|
|
G |
Aip |
aryl-hydrocarbon receptor-interacting protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of AIP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:201,408,002...201,419,220
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression |
EXP |
bromobenzene results in increased expression of AKR7A3 mRNA |
CTD |
PMID:12628495 PMID:15056800 PMID:32479839 |
|
NCBI chr 5:151,590,968...151,601,394
|
|
G |
Alad |
aminolevulinate dehydratase |
decreases activity multiple interactions decreases expression |
ISO EXP |
bromobenzene results in decreased activity of ALAD protein [Phenobarbital co-treated with bromobenzene] results in decreased activity of ALAD protein; Carbon Monoxide inhibits the reaction [[Phenobarbital co-treated with bromobenzene] results in decreased activity of ALAD protein] bromobenzene results in decreased expression of ALAD mRNA |
CTD |
PMID:6740708 PMID:16140629 PMID:32479839 |
|
NCBI chr 5:75,961,993...75,972,334
|
|
G |
Alb |
albumin |
increases expression affects binding |
EXP |
bromobenzene results in increased expression of ALB mRNA bromobenzene metabolite binds to ALB protein |
CTD |
PMID:12018992 PMID:17305373 PMID:23288050 |
|
NCBI chr14:17,891,564...17,907,043
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
affects binding increases expression |
EXP |
bromobenzene metabolite binds to ALDH1A1 protein bromobenzene results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:12628495 PMID:17305373 |
|
NCBI chr 1:218,000,470...218,152,962
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
affects binding |
EXP |
bromobenzene metabolite binds to ALDH2 protein |
CTD |
PMID:17305373 |
|
NCBI chr12:40,610,244...40,643,220
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
affects binding |
EXP |
bromobenzene metabolite binds to ALDH9A1 protein |
CTD |
PMID:17305373 |
|
NCBI chr13:82,038,679...82,055,478
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
increases expression |
EXP |
bromobenzene results in increased expression of ALOX15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:55,559,060...55,567,535
|
|
G |
Als2cl |
ALS2 C-terminal like |
increases expression |
EXP |
bromobenzene results in increased expression of ALS2CL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:110,863,753...110,884,434
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
increases expression |
EXP |
bromobenzene results in increased expression of AMBP mRNA |
CTD |
PMID:23288050 |
|
NCBI chr 5:76,568,094...76,578,416
|
|
G |
Angptl1 |
angiopoietin-like 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ANGPTL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:68,963,186...68,981,649
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
EXP |
bromobenzene results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:14,550,288...14,557,797
|
|
G |
Angptl8 |
angiopoietin-like 8 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ANGPTL8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:20,376,462...20,378,488
|
|
G |
Ankle1 |
ankyrin repeat and LEM domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ANKLE1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:18,076,413...18,082,356
|
|
G |
Ankmy1 |
ankyrin repeat and MYND domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ANKMY1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:100,869,899...100,924,030
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ANKRD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:233,815,851...233,834,891
|
|
G |
Ankrd13d |
ankyrin repeat domain 13D |
increases expression |
EXP |
bromobenzene results in increased expression of ANKRD13D mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:201,565,712...201,577,987
|
|
G |
Ankrd33b |
ankyrin repeat domain 33B |
increases expression |
EXP |
bromobenzene results in increased expression of ANKRD33B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:83,988,505...84,070,311
|
|
G |
Anln |
anillin, actin binding protein |
increases expression |
EXP |
bromobenzene results in increased expression of ANLN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:20,858,227...20,921,602
|
|
G |
Anxa13 |
annexin A13 |
increases expression |
EXP |
bromobenzene results in increased expression of ANXA13 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:89,884,356...89,936,907
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
increases expression |
EXP |
bromobenzene results in increased expression of APC mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:26,138,382...26,196,021
|
|
G |
Apoc3 |
apolipoprotein C3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of APOC3 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 8:46,531,478...46,533,658
|
|
G |
Apoh |
apolipoprotein H |
increases expression |
EXP |
bromobenzene results in increased expression of APOH mRNA |
CTD |
PMID:23288050 |
|
NCBI chr10:93,342,435...93,356,334
|
|
G |
Apold1 |
apolipoprotein L domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of APOLD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:169,499,728...169,557,075
|
|
G |
Apom |
apolipoprotein M |
increases expression |
EXP |
bromobenzene results in increased expression of APOM mRNA |
CTD |
PMID:12628495 |
|
NCBI chr20:3,690,950...3,693,550
|
|
G |
Aptx |
aprataxin |
decreases expression |
EXP |
bromobenzene results in decreased expression of APTX mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:55,798,896...55,822,963
|
|
G |
Arg1 |
arginase 1 |
affects binding increases expression |
EXP |
bromobenzene metabolite binds to ARG1 protein bromobenzene results in increased expression of ARG1 mRNA |
CTD |
PMID:17305373 PMID:32479839 |
|
NCBI chr 1:22,295,093...22,307,720
|
|
G |
Arhgap19 |
Rho GTPase activating protein 19 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ARHGAP19 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:240,571,554...240,617,361
|
|
G |
Arhgap32 |
Rho GTPase activating protein 32 |
increases expression |
EXP |
bromobenzene results in increased expression of ARHGAP32 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:30,421,269...30,681,653
|
|
G |
Arhgef19 |
Rho guanine nucleotide exchange factor 19 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ARHGEF19 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:153,536,038...153,554,203
|
|
G |
Arid5a |
AT-rich interaction domain 5A |
increases expression |
EXP |
bromobenzene results in increased expression of ARID5A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:38,534,612...38,549,467
|
|
G |
Armc7 |
armadillo repeat containing 7 |
increases expression |
EXP |
bromobenzene results in increased expression of ARMC7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:100,723,080...100,739,636
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:12,873,202...12,885,716
|
|
G |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ASB4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:33,506,992...33,544,630
|
|
G |
Asf1a |
anti-silencing function 1A histone chaperone |
increases expression |
EXP |
bromobenzene results in increased expression of ASF1A mRNA |
CTD |
PMID:12628495 |
|
NCBI chr20:32,893,962...32,908,808
|
|
G |
Asl |
argininosuccinate lyase |
increases expression |
EXP |
bromobenzene results in increased expression of ASL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:26,659,664...26,677,136
|
|
G |
Atp12a |
ATPase H+/K+ transporting non-gastric alpha2 subunit |
increases expression |
EXP |
bromobenzene results in increased expression of ATP12A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:30,443,571...30,468,229
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ATP1B1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:76,786,580...76,807,096
|
|
G |
Atp6v0d2 |
ATPase H+ transporting V0 subunit D2 |
increases expression |
EXP |
bromobenzene results in increased expression of ATP6V0D2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:33,336,257...33,385,354
|
|
G |
Atp6v1c2 |
ATPase H+ transporting V1 subunit C2 |
increases expression |
EXP |
bromobenzene results in increased expression of ATP6V1C2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:45,809,269...45,872,914
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
affects expression |
EXP |
bromobenzene affects the expression of AVPR1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:59,999,743...60,003,667
|
|
G |
B3galnt1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
increases expression |
EXP |
bromobenzene results in increased expression of B3GALNT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:153,847,297...153,877,371
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
EXP |
bromobenzene results in decreased expression of BAAT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:68,647,166...68,656,137
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
increases expression |
EXP |
bromobenzene results in increased expression of BACH1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:40,425,721...40,461,118
|
|
G |
Banp |
Btg3 associated nuclear protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of BANP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:50,007,710...50,082,742
|
|
G |
Bex1 |
brain expressed X-linked 1 |
increases expression |
EXP |
bromobenzene results in increased expression of BEX2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:99,219,014...99,220,518
|
|
G |
Bhlha15 |
basic helix-loop-helix family, member a15 |
decreases expression |
EXP |
bromobenzene results in decreased expression of BHLHA15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:15,534,123...15,538,299
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
decreases expression |
EXP |
bromobenzene results in decreased expression of BHLHE40 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:141,618,453...141,624,154
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression increases expression |
EXP |
bromobenzene results in decreased expression of BHMT mRNA bromobenzene results in increased expression of BHMT mRNA |
CTD |
PMID:12628495 PMID:15056800 PMID:32479839 |
|
NCBI chr 2:26,594,852...26,614,429
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of BMAL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:176,766,222...176,864,741
|
|
G |
Bmal2 |
basic helix-loop-helix ARNT like 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of BMAL2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:179,699,432...179,747,710
|
|
G |
Bmf |
Bcl2 modifying factor |
decreases expression |
EXP |
bromobenzene results in decreased expression of BMF mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:125,953,466...125,974,087
|
|
G |
Brinp2 |
BMP/retinoic acid inducible neural specific 2 |
increases expression |
EXP |
bromobenzene results in increased expression of BRINP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:70,431,006...70,532,766
|
|
G |
Btbd19 |
BTB domain containing 19 |
increases expression |
EXP |
bromobenzene results in increased expression of BTBD19 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:130,596,966...130,605,403
|
|
G |
C1qtnf7 |
C1q and TNF related 7 |
increases expression |
EXP |
bromobenzene results in increased expression of C1QTNF7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:67,467,888...67,580,477
|
|
G |
C1r |
complement C1r |
decreases expression |
EXP |
bromobenzene results in decreased expression of C1R mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 4:157,412,718...157,423,483
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
affects binding |
EXP |
bromobenzene metabolite binds to C8H11ORF54 protein |
CTD |
PMID:17305373 |
|
NCBI chr 8:12,123,839...12,146,412
|
|
G |
C8h15orf39 |
similar to human chromosome 15 open reading frame 39 |
increases expression |
EXP |
bromobenzene results in increased expression of C8H15ORF39 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:66,542,269...66,551,835
|
|
G |
C9 |
complement C9 |
decreases expression |
EXP |
bromobenzene results in decreased expression of C9 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:57,300,510...57,348,759
|
|
G |
Calml3 |
calmodulin-like 3 |
increases expression |
EXP |
bromobenzene results in increased expression of CALML3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:66,419,844...66,423,083
|
|
G |
Capn1 |
calpain 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CAPN1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 1:212,705,219...212,736,134
|
|
G |
Car1 |
carbonic anhydrase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CAR1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:88,550,681...88,593,454
|
|
G |
Car12 |
carbonic anhydrase 12 |
increases expression |
EXP |
bromobenzene results in increased expression of CA12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:67,274,739...67,330,428
|
|
G |
Car2 |
carbonic anhydrase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CAR2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:88,462,883...88,478,012
|
|
G |
Car3 |
carbonic anhydrase 3 |
affects binding decreases expression |
EXP |
bromobenzene metabolite binds to CA3 protein bromobenzene results in decreased expression of CA3 mRNA |
CTD |
PMID:17305373 PMID:32479839 |
|
NCBI chr 2:88,491,666...88,501,299
|
|
G |
Card19 |
caspase recruitment domain family, member 19 |
increases expression |
EXP |
bromobenzene results in increased expression of CARD19 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:15,432,632...15,445,317
|
|
G |
Cblc |
Cbl proto-oncogene C |
decreases expression |
EXP |
bromobenzene results in decreased expression of CBLC mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:88,567,930...88,584,709
|
|
G |
Ccdc106 |
coiled-coil domain containing 106 |
increases expression |
EXP |
bromobenzene results in increased expression of CCDC106 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:68,779,882...68,783,975
|
|
G |
Ccdc122 |
coiled-coil domain containing 122 |
increases expression |
EXP |
bromobenzene results in increased expression of CCDC122 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:52,407,717...52,470,163
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CCL7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:67,514,095...67,515,945
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CCN2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:22,621,498...22,624,614
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CCND1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:209,518,288...209,527,986
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CCNE1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:99,918,672...99,927,986
|
|
G |
Ccser2 |
coiled-coil serine-rich protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CCSER2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:12,613,103...12,725,764
|
|
G |
Cd274 |
CD274 molecule |
decreases expression |
EXP |
bromobenzene results in decreased expression of CD274 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:236,526,215...236,549,956
|
|
G |
Cd3e |
CD3 epsilon subunit of T-cell receptor complex |
increases expression |
EXP |
bromobenzene results in increased expression of CD3E mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:54,200,617...54,211,770
|
|
G |
Cd99l2 |
CD99 molecule-like 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CD99L2 mRNA |
CTD |
PMID:32479839 |
|
|
|
G |
Cdc34 |
cell division cycle 34, ubiquitin conjugating enzyme |
increases expression |
EXP |
bromobenzene results in increased expression of CDC34 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 7:10,017,588...10,023,586
|
|
G |
Cdh10 |
cadherin 10 |
increases expression |
EXP |
bromobenzene results in increased expression of CDH10 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:68,628,623...68,850,995
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
bromobenzene results in increased expression of CDKN1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:7,150,820...7,161,373
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
decreases expression increases expression |
EXP |
bromobenzene results in decreased expression of CDO1 mRNA bromobenzene results in increased expression of CDO1 mRNA |
CTD |
PMID:12628495 PMID:15056800 |
|
NCBI chr18:39,432,473...39,447,253
|
|
G |
Cds2 |
CDP-diacylglycerol synthase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CDS2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:119,514,963...119,553,555
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CDT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:67,529,249...67,534,195
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
decreases expression |
EXP |
bromobenzene results in decreased expression of CEBPD mRNA |
CTD |
PMID:12628495 |
|
NCBI chr11:84,764,670...84,765,808
|
|
G |
Cemip |
cell migration inducing hyaluronidase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CEMIP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:137,906,921...138,062,430
|
|
G |
Cenpk |
centromere protein K |
decreases expression |
EXP |
bromobenzene results in decreased expression of CENPK mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:35,360,390...35,421,372
|
|
G |
Cenpt |
centromere protein T |
increases expression |
EXP |
bromobenzene results in increased expression of CENPT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:50,644,548...50,651,048
|
|
G |
Cenpw |
centromere protein W |
increases expression |
EXP |
bromobenzene results in increased expression of CENPW mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:27,525,324...27,530,464
|
|
G |
Cfap184 |
cilia and flagella associated protein 184 |
increases expression |
EXP |
bromobenzene results in increased expression of CCDC96 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:74,276,568...74,279,072
|
|
G |
Cfap95 |
cilia and flagella associated protein 95 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CFAP95 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:221,123,786...221,242,963
|
|
G |
Cfl1 |
cofilin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CFL1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:212,227,124...212,230,656
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CHAC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:126,796,131...126,799,352
|
|
G |
Chmp4c |
charged multivesicular body protein 4C |
increases expression |
EXP |
bromobenzene results in increased expression of CHMP4C mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:91,391,729...91,428,652
|
|
G |
Chrdl1 |
chordin-like 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CHRDL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:106,889,125...106,992,937
|
|
G |
Chrna1 |
cholinergic receptor nicotinic alpha 1 subunit |
increases expression |
EXP |
bromobenzene results in increased expression of CHRNA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:78,862,286...78,877,353
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
increases expression |
EXP |
bromobenzene results in increased expression of CHRNA5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:55,369,794...55,398,526
|
|
G |
Ciart |
circadian associated repressor of transcription |
decreases expression |
EXP |
bromobenzene results in decreased expression of CIART mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:183,419,819...183,424,845
|
|
G |
Cimip6 |
ciliary microtubule inner protein 6 |
increases expression |
EXP |
bromobenzene results in increased expression of CIMIP6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:104,145,818...104,178,973
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
affects expression |
EXP |
bromobenzene affects the expression of CITED4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:134,246,936...134,247,827
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CLCF1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:201,507,763...201,517,607
|
|
G |
Cldn1 |
claudin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CLDN1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:87,926,376...87,941,533
|
|
G |
Cldn3 |
claudin 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CLDN3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:27,345,075...27,346,547
|
|
G |
Clec2dl1 |
C-type lectin domain family 2 member D-like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CLEC2DL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:162,263,635...162,274,882
|
|
G |
Clock |
clock circadian regulator |
increases expression |
EXP |
bromobenzene results in increased expression of CLOCK mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:32,262,747...32,346,872
|
|
G |
Clspn |
claspin |
decreases expression |
EXP |
bromobenzene results in decreased expression of CLSPN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:144,134,619...144,169,531
|
|
G |
Clstn3 |
calsyntenin 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CLSTN3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:157,331,494...157,364,769
|
|
G |
Cltb |
clathrin, light chain B |
increases expression |
EXP |
bromobenzene results in increased expression of CLTB mRNA |
CTD |
PMID:12628495 |
|
NCBI chr17:10,001,512...10,019,201
|
|
G |
Cntnap4 |
contactin associated protein family member 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CNTNAP4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:40,568,684...40,861,879
|
|
G |
Colq |
collagen like tail subunit of asymmetric acetylcholinesterase |
increases expression |
EXP |
bromobenzene results in increased expression of COLQ mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:6,731,850...6,824,973
|
|
G |
Coq10b |
coenzyme Q10B |
affects expression |
EXP |
bromobenzene affects the expression of COQ10B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:56,553,751...56,573,671
|
|
G |
Coro6 |
coronin 6 |
increases expression |
EXP |
bromobenzene results in increased expression of CORO6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:62,311,552...62,319,659
|
|
G |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CPEB2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:71,999,958...72,056,012
|
|
G |
Cpne1 |
copine 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CPNE1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:144,587,531...144,629,911
|
|
G |
Crat |
carnitine O-acetyltransferase |
increases expression |
EXP |
bromobenzene results in increased expression of CRAT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:13,675,684...13,689,282
|
|
G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
increases expression |
EXP |
bromobenzene results in increased expression of CREB3L3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:9,273,320...9,281,755
|
|
G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CREG1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:80,552,779...80,565,272
|
|
G |
Crmp1 |
collapsin response mediator protein 1 |
affects expression |
EXP |
bromobenzene affects the expression of CRMP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:73,509,933...73,556,192
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CRY1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:18,529,823...18,594,092
|
|
G |
Cryga |
crystallin, gamma A |
decreases expression |
EXP |
bromobenzene results in decreased expression of CRYGA mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:66,482,176...66,484,638
|
|
G |
Csad |
cysteine sulfinic acid decarboxylase |
increases expression |
EXP |
bromobenzene results in increased expression of CSAD mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 7:135,187,175...135,216,495
|
|
G |
Csmd1 |
CUB and Sushi multiple domains 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CSMD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:72,218,189...73,818,380
|
|
G |
Csnk2b |
casein kinase 2 beta |
increases expression |
EXP |
bromobenzene results in increased expression of CSNK2B mRNA |
CTD |
PMID:16036859 |
|
NCBI chr20:3,704,833...3,709,999
|
|
G |
Ctsl |
cathepsin L |
increases expression |
EXP |
bromobenzene results in increased expression of CTSL mRNA |
CTD |
PMID:12628495 |
|
NCBI chr17:770,104...776,266
|
|
G |
Cux2 |
cut-like homeobox 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CUX2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:34,507,723...34,707,581
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CXCL13 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:13,608,894...13,613,965
|
|
G |
Cxcr6 |
C-X-C motif chemokine receptor 6 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CXCR6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:123,434,417...123,439,568
|
|
G |
Cyb5a |
cytochrome b5 type A |
increases expression |
EXP |
bromobenzene results in increased expression of CYB5A mRNA |
CTD |
PMID:12628495 |
|
NCBI chr18:78,213,067...78,245,677
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
EXP |
bromobenzene results in increased expression of CYCS mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 4:80,982,667...80,984,767
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP17A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:245,535,462...245,543,148
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
affects expression |
EXP |
bromobenzene affects the expression of CYP1A1 protein |
CTD |
PMID:10445401 |
|
NCBI chr 8:66,991,940...66,998,014
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP26A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:235,471,368...235,475,204
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CYP26B1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:117,041,808...117,058,628
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP27B1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:64,756,626...64,761,570
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP2B2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:90,722,243...90,736,272
|
|
G |
Cyp2c12 |
cytochrome P450, family 2, subfamily c, polypeptide 12 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP2C12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:238,699,859...238,757,011
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP2E1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:205,269,967...205,280,365
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CYP3A9 mRNA |
CTD |
PMID:17538237 |
|
NCBI chr12:21,919,955...21,960,160
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP4A3 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 5:129,097,571...129,115,488
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CYP51 mRNA |
CTD |
PMID:12628495 PMID:32479839 |
|
NCBI chr 4:30,036,956...30,055,410
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP7A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:24,174,505...24,184,202
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
affects expression |
EXP |
bromobenzene affects the expression of CYP8B1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:130,455,622...130,457,592
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
decreases expression |
EXP |
bromobenzene results in decreased expression of DBP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:96,175,796...96,180,745
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of DDIT3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:65,001,695...65,006,517
|
|
G |
Ddt |
D-dopachrome tautomerase |
affects binding |
EXP |
bromobenzene metabolite binds to DDT protein |
CTD |
PMID:17305373 |
|
NCBI chr20:12,883,025...12,886,121
|
|
G |
Depp1 |
DEPP autophagy regulator 1 |
increases expression |
EXP |
bromobenzene results in increased expression of DEPP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:149,910,794...149,913,013
|
|
G |
Derl3 |
derlin 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of DERL3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:12,754,490...12,768,454
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
EXP |
bromobenzene results in decreased expression of DHCR7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:199,015,081...199,031,055
|
|
G |
Dhx40 |
DEAH-box helicase 40 |
increases expression |
EXP |
bromobenzene results in increased expression of DHX40 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:72,081,867...72,118,792
|
|
G |
Dipk1c |
divergent protein kinase domain 1C |
increases expression |
EXP |
bromobenzene results in increased expression of DIPK1C mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:78,087,972...78,109,910
|
|
G |
Disp1 |
dispatched RND transporter family member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of DISP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:94,720,928...94,866,695
|
|
G |
Dlgap5 |
DLG associated protein 5 |
increases expression |
EXP |
bromobenzene results in increased expression of DLGAP5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:20,633,964...20,664,569
|
|
G |
Dmtn |
dematin actin binding protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of DMTN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:45,677,974...45,702,261
|
|
G |
Dnah17 |
dynein, axonemal, heavy chain 17 |
increases expression |
EXP |
bromobenzene results in increased expression of DNAH17 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:103,244,144...103,364,953
|
|
G |
Dnase1l2 |
deoxyribonuclease 1 like 2 |
increases expression |
EXP |
bromobenzene results in increased expression of DNASE1L2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:13,471,850...13,473,447
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
increases expression |
EXP |
bromobenzene results in increased expression of DNMT3B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:142,130,588...142,169,128
|
|
G |
Dok7 |
docking protein 7 |
increases expression |
EXP |
bromobenzene results in increased expression of DOK7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:75,665,444...75,699,413
|
|
G |
Dpp6 |
dipeptidyl peptidase like 6 |
decreases expression |
EXP |
bromobenzene results in decreased expression of DPP6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:7,589,386...8,508,666
|
|
G |
Dr1 |
down-regulator of transcription 1 |
increases expression |
EXP |
bromobenzene results in increased expression of DR1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:1,458,223...1,469,578
|
|
G |
Dsc2 |
desmocollin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of DSC2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:11,725,466...11,757,591
|
|
G |
Dtx3 |
deltex E3 ubiquitin ligase 3 |
increases expression |
EXP |
bromobenzene results in increased expression of DTX3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:63,013,769...63,018,431
|
|
G |
Duoxa1 |
dual oxidase maturation factor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of DUOXA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:109,249,815...109,260,511
|
|
G |
Dus4l |
dihydrouridine synthase 4-like |
increases expression |
EXP |
bromobenzene results in increased expression of DUS4L mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:48,228,111...48,242,553
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
decreases expression |
EXP |
bromobenzene results in decreased expression of DUSP6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:35,979,502...35,983,834
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
increases expression |
EXP |
bromobenzene results in increased expression of DUSP8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:197,167,392...197,184,285
|
|
G |
Dynlt4 |
dynein light chain Tctex-type 4 |
increases expression |
EXP |
bromobenzene results in increased expression of DYNLT4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:130,605,437...130,607,224
|
|
G |
E2f7 |
E2F transcription factor 7 |
increases expression |
EXP |
bromobenzene results in increased expression of E2F7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:48,036,881...48,079,055
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ECI1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:13,456,715...13,470,061
|
|
G |
Ecm2 |
extracellular matrix protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of ECM2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:15,120,194...15,152,536
|
|
G |
Edar |
ectodysplasin-A receptor |
decreases expression |
EXP |
bromobenzene results in decreased expression of EDAR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:26,587,836...26,666,543
|
|
G |
Eea1 |
early endosome antigen 1 |
increases expression |
EXP |
bromobenzene results in increased expression of EEA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:30,554,686...30,722,186
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
multiple interactions |
EXP |
[bromobenzene co-treated with EGLN1 mutant form] results in increased expression of HIF1A protein; [bromobenzene co-treated with EGLN1 mutant form] results in increased expression of HMOX1 mRNA; [bromobenzene co-treated with EGLN1 mutant form] results in increased expression of PTGS2 mRNA |
CTD |
PMID:24190904 |
|
NCBI chr19:52,867,900...52,907,308
|
|
G |
Eif3c |
eukaryotic translation initiation factor 3, subunit C |
increases expression |
EXP |
bromobenzene results in increased expression of EIF3C mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:181,134,604...181,152,489
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
increases expression |
EXP |
bromobenzene results in increased expression of EIF5A mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:55,138,821...55,143,272
|
|
G |
Eno1 |
enolase 1 |
affects binding |
EXP |
bromobenzene metabolite binds to ENO1 protein |
CTD |
PMID:17305373 |
|
NCBI chr 5:160,719,951...160,731,337
|
|
G |
Enpp7 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ENPP7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:104,242,169...104,247,185
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of EPHX1 mRNA |
CTD |
PMID:12628495 PMID:17538237 PMID:32479839 |
|
NCBI chr13:95,246,079...95,275,852
|
|
G |
Epop |
elongin BC and polycomb repressive complex 2 associated protein |
increases expression |
EXP |
bromobenzene results in increased expression of EPOP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:82,624,392...82,625,912
|
|
G |
Eps8l3 |
EPS8 signaling adaptor L3 |
increases expression |
EXP |
bromobenzene results in increased expression of EPS8L3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:195,514,692...195,528,085
|
|
G |
Erich5 |
glutamate-rich 5 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ERICH5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:65,655,829...65,682,221
|
|
G |
Ero1b |
endoplasmic reticulum oxidoreductase 1 beta |
increases expression |
EXP |
bromobenzene results in increased expression of ERO1B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:92,913,696...92,987,401
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
affects binding |
EXP |
bromobenzene metabolite binds to ERP29 protein |
CTD |
PMID:12018992 |
|
NCBI chr12:40,750,177...40,756,607
|
|
G |
Etnppl |
ethanolamine-phosphate phospho-lyase |
increases expression |
EXP |
bromobenzene results in increased expression of ETNPPL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:219,173,048...219,194,646
|
|
G |
Eva1c |
eva-1 homolog C |
increases expression |
EXP |
bromobenzene results in increased expression of EVA1C mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:30,089,510...30,163,596
|
|
G |
F12 |
coagulation factor XII |
increases expression |
EXP |
bromobenzene results in increased expression of F12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:9,212,819...9,220,664
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
decreases expression affects binding |
EXP |
bromobenzene results in decreased expression of FABP1 mRNA bromobenzene metabolite binds to FABP1 protein |
CTD |
PMID:12628495 PMID:17305373 |
|
NCBI chr 4:104,744,302...104,753,119
|
|
G |
Fabp12 |
fatty acid binding protein 12 |
increases expression |
EXP |
bromobenzene results in increased expression of FABP12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:91,539,568...91,554,999
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
affects binding |
EXP |
bromobenzene metabolite binds to FABP7 protein |
CTD |
PMID:17305373 |
|
NCBI chr20:37,123,193...37,126,725
|
|
G |
Fads1 |
fatty acid desaturase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FADS1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:216,252,605...216,267,618
|
|
G |
Fads2 |
fatty acid desaturase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FADS2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:206,707,384...206,747,333
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
affects binding |
EXP |
bromobenzene metabolite binds to FAH protein |
CTD |
PMID:17305373 |
|
NCBI chr 1:138,548,830...138,571,599
|
|
G |
Fam180a |
family with sequence similarity 180, member A |
increases expression |
EXP |
bromobenzene results in increased expression of FAM180A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:63,992,867...64,008,047
|
|
G |
Fam222a |
family with sequence similarity 222, member A |
increases expression |
EXP |
bromobenzene results in increased expression of FAM222A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:41,982,064...42,033,085
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
increases expression |
EXP |
bromobenzene results in increased expression of FAM83D mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:167,841,748...167,861,062
|
|
G |
Fam83f |
family with sequence similarity 83, member F |
increases expression |
EXP |
bromobenzene results in increased expression of FAM83F mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:112,211,164...112,240,454
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
decreases expression |
EXP |
bromobenzene results in decreased expression of FAM89A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:52,710,002...52,722,630
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
EXP |
bromobenzene results in decreased expression of FASN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:106,570,415...106,588,581
|
|
G |
Fbn2 |
fibrillin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of FBN2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:51,499,670...51,703,976
|
|
G |
Fbxo30 |
F-box protein 30 |
increases expression |
EXP |
bromobenzene results in increased expression of FBXO30 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:5,655,341...5,671,558
|
|
G |
Fcamr |
Fc alpha and mu receptor |
increases expression |
EXP |
bromobenzene results in increased expression of FCAMR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:42,273,891...42,288,002
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FDFT1 mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr15:41,588,114...41,616,168
|
|
G |
Fdps |
farnesyl diphosphate synthase |
decreases expression |
EXP |
bromobenzene results in decreased expression of FDPS mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr 2:176,795,192...176,804,816
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FEN1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:216,270,016...216,274,873
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
increases expression |
EXP |
bromobenzene results in increased expression of FGF21 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:105,219,825...105,221,376
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
EXP |
bromobenzene results in decreased expression of FGG mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:168,354,880...168,362,325
|
|
G |
Fgl1 |
fibrinogen-like 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FGL1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr16:51,120,652...51,150,907
|
|
G |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
decreases expression |
EXP |
bromobenzene results in decreased expression of FGR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:150,473,767...150,503,524
|
|
G |
Fibin |
fin bud initiation factor homolog |
increases expression |
EXP |
bromobenzene results in increased expression of FIBIN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:96,942,405...96,944,676
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
increases expression |
EXP |
bromobenzene results in increased expression of FKBP5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:6,458,931...6,577,227
|
|
G |
Flii |
FLII, actin remodeling protein |
increases expression |
EXP |
bromobenzene results in increased expression of FLII mRNA |
CTD |
PMID:12628495 PMID:16036859 |
|
NCBI chr10:45,893,566...45,907,547
|
|
G |
Flnb |
filamin B |
increases expression |
EXP |
bromobenzene results in increased expression of FLNB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:16,961,999...17,095,059
|
|
G |
Flvcr2 |
FLVCR choline and putative heme transporter 2 |
increases expression |
EXP |
bromobenzene results in increased expression of FLVCR2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:105,408,355...105,472,355
|
|
G |
Fmnl1 |
formin-like 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FMNL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:88,115,876...88,143,342
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of FMO1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr13:75,182,184...75,214,439
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of FMO2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:75,221,149...75,244,377
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
increases expression |
EXP |
bromobenzene results in increased expression of FMO3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:75,309,367...75,334,915
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FN1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 9:80,645,507...80,714,200
|
|
G |
Fndc1 |
fibronectin type III domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of FNDC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:47,281,839...47,364,247
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
decreases expression |
EXP |
bromobenzene results in decreased expression of FOSL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:212,183,885...212,192,391
|
|
G |
Fstl3 |
follistatin like 3 |
increases expression |
EXP |
bromobenzene results in increased expression of FSTL3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:9,923,574...9,929,223
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
EXP |
bromobenzene results in increased expression of FTH1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:216,052,037...216,054,325
|
|
G |
Fut1 |
fucosyltransferase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of FUT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:96,086,934...96,090,352
|
|
G |
Fzd7 |
frizzled class receptor 7 |
increases expression |
EXP |
bromobenzene results in increased expression of FZD7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:60,931,433...60,934,252
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
EXP |
bromobenzene results in increased expression of G6PDX mRNA |
CTD |
PMID:12628495 |
|
NCBI chr X:157,352,364...157,372,144
|
|
G |
Gad2 |
glutamate decarboxylase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of GAD2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:89,671,718...89,734,246
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
EXP |
bromobenzene results in increased expression of GADD45A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:97,484,497...97,486,799
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression |
EXP |
bromobenzene results in increased expression of GADD45B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:9,428,689...9,430,991
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
decreases expression |
EXP |
bromobenzene results in decreased expression of GADD45G mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:13,528,606...13,530,351
|
|
G |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of GAL3ST1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:83,094,265...83,109,992
|
|
G |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GALNT2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:69,110,657...69,222,237
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
affects binding |
EXP |
bromobenzene metabolite binds to GAMT protein |
CTD |
PMID:17305373 |
|
NCBI chr 7:10,099,267...10,102,083
|
|
G |
Gast |
gastrin |
decreases expression |
EXP |
bromobenzene results in decreased expression of GAST mRNA |
CTD |
PMID:15976192 |
|
NCBI chr10:85,264,832...85,269,393
|
|
G |
Gba3 |
glucosylceramidase beta 3 |
increases expression |
EXP |
bromobenzene results in increased expression of GBA3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:60,574,974...60,721,411
|
|
G |
Gbp2 |
guanylate binding protein 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GBP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:234,005,727...234,021,812
|
|
G |
Gbp3 |
guanylate binding protein 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GBP3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:231,460,032...231,500,266
|
|
G |
Gc |
GC, vitamin D binding protein |
increases expression |
EXP |
bromobenzene results in increased expression of GC mRNA |
CTD |
PMID:15056800 PMID:23288050 |
|
NCBI chr14:18,632,146...18,667,563
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
bromobenzene results in increased expression of GCLC protein |
CTD |
PMID:18078705 |
|
NCBI chr 8:87,510,251...87,548,896
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
EXP |
bromobenzene results in increased expression of GCLM mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:213,032,135...213,052,192
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
EXP |
bromobenzene results in increased expression of GDF15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:18,838,436...18,842,022
|
|
G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
increases expression |
EXP |
bromobenzene results in increased expression of GEM mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:25,214,309...25,225,222
|
|
G |
Gfm1 |
G elongation factor, mitochondrial 1 |
increases expression |
EXP |
bromobenzene results in increased expression of GFM1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:154,010,601...154,055,523
|
|
G |
Ghrhr |
growth hormone releasing hormone receptor |
decreases response to substance |
ISO |
GHRHR gene mutant form results in decreased susceptibility to bromobenzene |
CTD |
PMID:17521389 |
|
NCBI chr 4:84,498,159...84,532,851
|
|
G |
Gimd1 |
GIMAP family P-loop NTPase domain containing 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GIMD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:221,103,878...221,138,559
|
|
G |
Gja4 |
gap junction protein, alpha 4 |
increases expression |
EXP |
bromobenzene results in increased expression of GJA4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:139,633,324...139,635,857
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
increases expression |
EXP |
bromobenzene results in increased expression of GJB2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:31,260,390...31,278,222
|
|
G |
Gli3 |
GLI family zinc finger 3 |
increases expression |
EXP |
bromobenzene results in increased expression of GLI3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:54,134,064...54,405,198
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
increases activity |
EXP |
bromobenzene results in increased activity of GLUD1 protein |
CTD |
PMID:3012827 |
|
NCBI chr16:9,640,312...9,673,961
|
|
G |
Gnat1 |
G protein subunit alpha transducin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of GNAT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:108,350,935...108,355,671
|
|
G |
Gnmt |
glycine N-methyltransferase |
affects binding |
EXP |
bromobenzene metabolite binds to GNMT protein |
CTD |
PMID:17305373 |
|
NCBI chr 9:14,254,675...14,258,028
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of GOT1 mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr 1:252,306,541...252,337,622
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
increases expression |
EXP |
bromobenzene results in increased expression of GPAT3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:8,715,367...8,768,051
|
|
G |
Gpatch4 |
G patch domain containing 4 |
increases expression |
EXP |
bromobenzene results in increased expression of GPATCH4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:173,499,700...173,520,346
|
|
G |
Gpbp1l1 |
GC-rich promoter binding protein 1-like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of GPBP1L1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:135,245,188...135,287,299
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
affects binding |
EXP |
bromobenzene metabolite binds to GPD1 protein |
CTD |
PMID:17305373 |
|
NCBI chr 7:130,842,526...130,851,530
|
|
G |
Gpr21 |
G protein-coupled receptor 21 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GPR21 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:21,275,289...21,279,008
|
|
G |
Gpr39 |
G protein-coupled receptor 39 |
increases expression |
EXP |
bromobenzene results in increased expression of GPR39 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:37,115,258...37,327,312
|
|
G |
Gpr65 |
G-protein coupled receptor 65 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GPR65 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:117,515,786...117,536,514
|
|
G |
Gprin3 |
GPRIN family member 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GPRIN3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:88,572,062...88,657,369
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions increases activity |
ISO EXP |
diisopropyl 1,3-dithiol-2-ylidenemalonate inhibits the reaction [bromobenzene results in increased activity of GPT protein] |
CTD |
PMID:3795300 PMID:32479839 |
|
NCBI chr 7:110,295,599...110,300,134
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GPX1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 8:117,905,462...117,906,588
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of GPX2 mRNA |
CTD |
PMID:17538237 |
|
NCBI chr 6:101,226,745...101,230,033
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
EXP |
bromobenzene results in increased expression of GSTA2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 8:79,184,535...79,196,827
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression |
EXP |
bromobenzene results in increased expression of GSTA5 mRNA |
CTD |
PMID:17538237 |
|
NCBI chr 8:79,105,561...79,117,472
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression affects binding |
EXP |
bromobenzene results in increased expression of GSTM1 mRNA bromobenzene metabolite binds to GSTM1 protein |
CTD |
PMID:12628495 PMID:17305373 |
|
NCBI chr 2:198,338,005...198,346,007
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
affects binding |
EXP |
bromobenzene metabolite binds to GSTM2 protein |
CTD |
PMID:17305373 |
|
NCBI chr 2:195,624,015...195,628,774
|
|
G |
Gstp3 |
glutathione S-transferase pi 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GSTP3 mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr 1:201,355,682...201,358,216
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GSTT1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr20:12,856,068...12,873,020
|
|
G |
Gucy1b2 |
guanylate cyclase 1 soluble subunit beta 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GUCY1B2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:36,589,501...36,669,441
|
|
G |
Gzma |
granzyme A |
decreases expression |
EXP |
bromobenzene results in decreased expression of GZMA mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:44,740,569...44,752,502
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
decreases expression |
EXP |
bromobenzene results in decreased expression of HAMP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:95,298,332...95,300,271
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HAO2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:186,200,137...186,232,997
|
|
G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HBA-A1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:15,337,265...15,338,121
|
|
G |
Hbb |
hemoglobin subunit beta |
affects binding |
EXP |
bromobenzene metabolite binds to HBB protein |
CTD |
PMID:17305373 |
|
NCBI chr 1:167,662,310...167,663,721
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
increases expression |
EXP |
bromobenzene results in increased expression of HBEGF mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:28,380,337...28,390,220
|
|
G |
Hemgn |
hemogen |
increases expression |
EXP |
bromobenzene results in increased expression of HEMGN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:60,679,633...60,698,597
|
|
G |
Hes6 |
hes family bHLH transcription factor 6 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HES6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:99,449,375...99,451,343
|
|
G |
Hhip |
Hedgehog-interacting protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of HHIP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:27,863,684...27,952,528
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
[bromobenzene co-treated with EGLN1 mutant form] results in increased expression of HIF1A protein |
CTD |
PMID:24190904 |
|
NCBI chr 6:98,357,788...98,405,068
|
|
G |
Hif3a |
hypoxia inducible factor 3 subunit alpha |
increases expression |
EXP |
bromobenzene results in increased expression of HIF3A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:77,718,110...77,750,448
|
|
G |
Hjurp |
Holliday junction recognition protein |
increases expression |
EXP |
bromobenzene results in increased expression of HJURP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:96,301,183...96,315,587
|
|
G |
Hjv |
hemojuvelin BMP co-receptor |
increases expression |
EXP |
bromobenzene results in increased expression of HJV mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:186,754,801...186,758,708
|
|
G |
Hk3 |
hexokinase 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HK3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:9,602,119...9,620,038
|
|
G |
Hlf |
HLF transcription factor, PAR bZIP family member |
decreases expression |
EXP |
bromobenzene results in decreased expression of HLF mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:75,651,320...75,708,979
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr 2:53,379,457...53,399,807
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HMGCS2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:185,875,609...185,903,505
|
|
G |
Hmgn5 |
high mobility group nucleosome binding domain 5 |
increases expression |
EXP |
bromobenzene results in increased expression of HMGN5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:78,161,439...78,170,613
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO EXP |
bromobenzene results in increased expression of HMOX1 protein bromobenzene results in increased expression of HMOX1 mRNA; bromobenzene results in increased expression of HMOX1 protein [bromobenzene co-treated with EGLN1 mutant form] results in increased expression of HMOX1 mRNA |
CTD |
PMID:3343248 PMID:12628495 PMID:15056800 PMID:15976192 PMID:18078705 PMID:24190904 PMID:32479839 More...
|
|
NCBI chr19:13,452,365...13,479,823
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
increases expression |
EXP |
bromobenzene results in increased expression of HNF4A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:152,186,787...152,248,320
|
|
G |
Homer2 |
homer scaffold protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of HOMER2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:135,558,977...135,659,780
|
|
G |
Hpdl |
4-hydroxyphenylpyruvate dioxygenase-like |
increases expression |
EXP |
bromobenzene results in increased expression of HPDL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:135,523,258...135,524,864
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HSD11B2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:50,307,569...50,312,812
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HSD17B2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:45,753,576...45,825,203
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HSD17B7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:82,170,079...82,190,018
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression |
ISO |
bromobenzene results in increased expression of HSPA1A mRNA; bromobenzene results in increased expression of HSPA1A protein |
CTD |
PMID:8917683 |
|
NCBI chr20:3,875,411...3,877,866
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
EXP |
bromobenzene results in increased expression of HSPA1B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:3,859,756...3,863,800
|
|
G |
Hspa4l |
heat shock protein family A (Hsp70) member 4 like |
decreases expression |
EXP |
bromobenzene results in decreased expression of HSPA4L mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:123,740,384...123,793,088
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression increases expression affects binding |
EXP |
bromobenzene results in decreased expression of HSPA5 mRNA bromobenzene results in increased expression of HSPA5 mRNA bromobenzene metabolite binds to HSPA5 protein |
CTD |
PMID:12018992 PMID:12628495 PMID:15056800 |
|
NCBI chr 3:38,453,016...38,457,475
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
affects binding |
EXP |
bromobenzene metabolite binds to HSPA8 protein |
CTD |
PMID:17305373 |
|
NCBI chr 8:50,080,514...50,084,376
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of HTATIP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:108,609,424...108,624,810
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
bromobenzene analog results in increased expression of ICAM1 protein |
CTD |
PMID:19427879 |
|
NCBI chr 8:27,829,688...27,841,618
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
increases expression |
EXP |
bromobenzene results in increased expression of ID2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:47,469,162...47,470,995
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
affects binding |
EXP |
bromobenzene metabolite binds to IDH1 protein |
CTD |
PMID:17305373 |
|
NCBI chr 9:66,534,146...66,563,703
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IDI1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:61,629,592...61,637,357
|
|
G |
Ier3 |
immediate early response 3 |
increases expression |
EXP |
bromobenzene results in increased expression of IER3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:2,933,173...2,934,377
|
|
G |
Ifi27l2a |
interferon, alpha-inducible protein 27 like 2A |
decreases expression |
EXP |
bromobenzene results in decreased expression of ISG12(B) mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 6:122,598,872...122,600,358
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
increases expression |
EXP |
bromobenzene results in increased expression of IFRD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:62,996,560...63,044,996
|
|
G |
Ift122 |
intraflagellar transport 122 |
increases expression |
EXP |
bromobenzene results in increased expression of IFT122 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:148,905,031...148,975,458
|
|
G |
Igdcc3 |
immunoglobulin superfamily, DCC subclass, member 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IGDCC3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:65,661,165...65,707,961
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IGF1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 7:24,169,608...24,249,446
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of IGFBP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:74,415,574...74,442,945
|
|
G |
Igsf7l1 |
immunoglobulin superfamily, member 7 like 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IGSF7L1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:100,174,955...100,182,713
|
|
G |
Ihh |
Indian hedgehog signaling molecule |
decreases expression |
EXP |
bromobenzene results in decreased expression of IHH mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:76,504,315...76,510,532
|
|
G |
Ikzf4 |
IKAROS family zinc finger 4 |
increases expression |
EXP |
bromobenzene results in increased expression of IKZF4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:1,063,283...1,102,940
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IL13RA2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:115,814,620...115,886,080
|
|
G |
Il17rb |
interleukin 17 receptor B |
increases expression |
EXP |
bromobenzene results in increased expression of IL17RB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:5,186,961...5,200,657
|
|
G |
Il6r |
interleukin 6 receptor |
increases expression |
EXP |
bromobenzene results in increased expression of IL6R mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:177,582,020...177,646,705
|
|
G |
Inhba |
inhibin subunit beta A |
decreases expression |
EXP |
bromobenzene results in decreased expression of INHBA mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:53,787,159...53,810,942
|
|
G |
Inka1 |
inka box actin regulator 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of INKA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:108,674,263...108,675,953
|
|
G |
Inpp4b |
inositol polyphosphate-4-phosphatase type II B |
increases expression |
EXP |
bromobenzene results in increased expression of INPP4B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:42,824,710...43,575,039
|
|
G |
Insc |
INSC, spindle orientation adaptor protein |
increases expression |
EXP |
bromobenzene results in increased expression of INSC mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:168,993,032...169,100,438
|
|
G |
Insig1 |
insulin induced gene 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of INSIG1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:8,049,339...8,057,812
|
|
G |
Insig2 |
insulin induced gene 2 |
increases expression |
EXP |
bromobenzene results in increased expression of INSIG2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:32,472,390...32,500,139
|
|
G |
Ip6k2 |
inositol hexakisphosphate kinase 2 |
affects expression |
EXP |
bromobenzene affects the expression of IP6K2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:118,362,154...118,388,668
|
|
G |
Iqgap3 |
IQ motif containing GTPase activating protein 3 |
increases expression |
EXP |
bromobenzene results in increased expression of IQGAP3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:173,542,151...173,583,956
|
|
G |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of IRF2BP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:54,559,417...54,565,096
|
|
G |
Irs2 |
insulin receptor substrate 2 |
increases expression |
EXP |
bromobenzene results in increased expression of IRS2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:85,190,310...85,214,543
|
|
G |
Irx1 |
iroquois homeobox 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IRX1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:31,294,615...31,300,444
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ITIH4 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr16:6,080,539...6,095,710
|
|
G |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
increases expression |
EXP |
bromobenzene results in increased expression of JAKMIP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:73,646,299...73,766,830
|
|
G |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of JAKMIP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:35,532,552...35,747,938
|
|
G |
Kcnf1 |
potassium voltage-gated channel modifier subfamily F member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of KCNF1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:39,962,301...39,964,979
|
|
G |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
decreases expression |
EXP |
bromobenzene results in decreased expression of KCNJ15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:34,577,397...34,621,725
|
|
G |
Kcnk1 |
potassium two pore domain channel subfamily K member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of KCNK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:53,959,411...53,997,726
|
|
G |
Kcnk2 |
potassium two pore domain channel subfamily K member 2 |
increases expression |
EXP |
bromobenzene results in increased expression of KCNK2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:100,766,101...100,963,435
|
|
G |
Kcnt1 |
potassium sodium-activated channel subfamily T member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of KCNT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:29,081,071...29,136,902
|
|
G |
Kctd15 |
potassium channel tetramerization domain containing 15 |
increases expression |
EXP |
bromobenzene results in increased expression of KCTD15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:87,258,658...87,271,979
|
|
G |
Kif23 |
kinesin family member 23 |
increases expression |
EXP |
bromobenzene results in increased expression of KIF23 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:71,293,439...71,321,911
|
|
G |
Kif6 |
kinesin family member 6 |
increases expression |
EXP |
bromobenzene results in increased expression of KIF6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:11,076,203...11,373,205
|
|
G |
Kir3dl1 |
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 |
increases expression |
EXP |
bromobenzene results in increased expression of KIR3DL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:69,715,529...69,754,050
|
|
G |
Kirrel3 |
kirre like nephrin family adhesion molecule 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of KIRREL3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:32,865,779...33,407,555
|
|
G |
Klc3 |
kinesin light chain 3 |
affects binding |
EXP |
bromobenzene metabolite binds to KLC3 protein |
CTD |
PMID:17305373 |
|
NCBI chr 1:79,045,842...79,055,809
|
|
G |
Klf10 |
KLF transcription factor 10 |
increases expression |
EXP |
bromobenzene results in increased expression of KLF10 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:71,352,612...71,358,680
|
|
G |
Klf12 |
KLF transcription factor 12 |
decreases expression |
EXP |
bromobenzene results in decreased expression of KLF12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:83,037,548...83,469,998
|
|
G |
Klf15 |
KLF transcription factor 15 |
increases expression |
EXP |
bromobenzene results in increased expression of KLF15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:122,965,718...122,978,403
|
|
G |
Klf9 |
KLF transcription factor 9 |
increases expression |
EXP |
bromobenzene results in increased expression of KLF9 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:220,700,108...220,725,110
|
|
G |
Krt23 |
keratin 23 |
increases expression |
EXP |
bromobenzene results in increased expression of KRT23 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:84,930,603...84,946,929
|
|
G |
Lad1 |
ladinin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of LAD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:47,249,605...47,263,967
|
|
G |
Lap3 |
leucine aminopeptidase 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of LAP3 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr14:65,608,375...65,627,359
|
|
G |
Ldhb |
lactate dehydrogenase B |
decreases expression |
EXP |
bromobenzene results in decreased expression of LDHB mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 4:175,428,382...175,446,403
|
|
G |
Ldlr |
low density lipoprotein receptor |
decreases expression |
EXP |
bromobenzene results in decreased expression of LDLR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:20,270,020...20,292,981
|
|
G |
Lgi2 |
leucine-rich repeat LGI family, member 2 |
increases expression |
EXP |
bromobenzene results in increased expression of LGI2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:58,415,965...58,443,450
|
|
G |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
decreases expression |
EXP |
bromobenzene results in decreased expression of LGR5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:52,973,151...53,107,964
|
|
G |
Lgsn |
lengsin, lens protein with glutamine synthetase domain |
decreases expression |
EXP |
bromobenzene results in decreased expression of LGSN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:33,416,362...33,447,919
|
|
G |
Lonp1 |
lon peptidase 1, mitochondrial |
increases expression |
EXP |
bromobenzene results in increased expression of LONP1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 9:1,447,444...1,459,771
|
|
G |
Lonrf3 |
LON peptidase N-terminal domain and ring finger 3 |
increases expression |
EXP |
bromobenzene results in increased expression of LONRF3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:115,565,214...115,603,886
|
|
G |
Lox |
lysyl oxidase |
increases expression |
EXP |
bromobenzene results in increased expression of LOX mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:45,964,544...45,977,431
|
|
G |
Lpar3 |
lysophosphatidic acid receptor 3 |
increases expression |
EXP |
bromobenzene results in increased expression of LPAR3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:235,125,234...235,193,916
|
|
G |
Lpin1 |
lipin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of LPIN1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:45,039,110...45,145,845
|
|
G |
Lrrc4 |
leucine rich repeat containing 4 |
increases expression |
EXP |
bromobenzene results in increased expression of LRRC4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:57,433,518...57,437,114
|
|
G |
Lrrc58 |
leucine rich repeat containing 58 |
increases expression |
EXP |
bromobenzene results in increased expression of LRRC58 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:62,850,507...62,862,829
|
|
G |
Lst1 |
leukocyte specific transcript 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of LST1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:3,634,680...3,639,731
|
|
G |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of LTBP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:110,161,029...110,261,586
|
|
G |
Lypd1 |
Ly6/Plaur domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of LYPD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:37,326,459...37,368,515
|
|
G |
Lypd3 |
Ly6/Plaur domain containing 3 |
affects expression |
EXP |
bromobenzene affects the expression of LYPD3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:80,226,449...80,230,901
|
|
G |
Mab21l3 |
mab-21 like 3 |
increases expression |
EXP |
bromobenzene results in increased expression of MAB21L3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:189,248,895...189,271,652
|
|
G |
Mafb |
MAF bZIP transcription factor B |
increases expression |
EXP |
bromobenzene results in increased expression of MAFB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:169,417,890...169,419,810
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
EXP |
bromobenzene results in increased expression of MAFF mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:112,792,787...112,804,139
|
|
G |
Magi3 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MAGI3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:191,514,726...191,717,048
|
|
G |
Mal |
mal, T-cell differentiation protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of MAL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:114,864,378...114,888,136
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
increases expression |
EXP |
bromobenzene results in increased expression of MAP3K5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:16,505,387...16,723,899
|
|
G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
increases expression |
EXP |
bromobenzene results in increased expression of MAP3K6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:150,724,029...150,736,113
|
|
G |
Map3k9 |
mitogen-activated protein kinase kinase kinase 9 |
increases expression |
EXP |
bromobenzene results in increased expression of MAP3K9 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:107,155,008...107,220,304
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
increases phosphorylation |
ISO |
bromobenzene analog results in increased phosphorylation of MAPK14 protein |
CTD |
PMID:19427879 |
|
NCBI chr20:6,751,288...6,812,294
|
|
G |
Mapkapk3 |
MAPK activated protein kinase 3 |
increases expression |
EXP |
bromobenzene results in increased expression of MAPKAPK3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:116,808,429...116,842,228
|
|
G |
Marchf1 |
membrane associated ring-CH-type finger 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MARCHF1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:23,255,551...24,114,290
|
|
G |
Mat1a |
methionine adenosyltransferase 1A |
increases expression |
EXP |
bromobenzene results in increased expression of MAT1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:16,983,084...17,001,284
|
|
G |
Mb |
myoglobin |
decreases expression |
EXP |
bromobenzene results in decreased expression of MB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:110,640,511...110,647,742
|
|
G |
Mcf2 |
MCF.2 cell line derived transforming sequence |
increases expression |
EXP |
bromobenzene results in increased expression of MCF2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:138,414,077...138,514,828
|
|
G |
Mcm10 |
minichromosome maintenance 10 replication initiation factor |
increases expression |
EXP |
bromobenzene results in increased expression of MCM10 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:78,172,049...78,197,644
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MCM3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:30,715,602...30,733,746
|
|
G |
Mcm6 |
minichromosome maintenance complex component 6 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MCM6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:42,379,161...42,404,352
|
|
G |
Mcoln2 |
mucolipin TRP cation channel 2 |
increases expression |
EXP |
bromobenzene results in increased expression of MCOLN2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:237,714,100...237,762,979
|
|
G |
Mcub |
mitochondrial calcium uniporter dominant negative subunit beta |
increases expression |
EXP |
bromobenzene results in increased expression of MCUB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:218,479,301...218,549,594
|
|
G |
Mdh1b |
malate dehydrogenase 1B |
decreases expression |
EXP |
bromobenzene results in decreased expression of MDH1B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:65,120,370...65,168,008
|
|
G |
Meiob |
meiosis specific with OB-fold |
decreases expression |
EXP |
bromobenzene results in decreased expression of MEIOB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:13,833,170...13,865,684
|
|
G |
Metap2 |
methionyl aminopeptidase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of METAP2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 7:28,412,429...28,440,458
|
|
G |
Mex3b |
mex-3 RNA binding family member B |
increases expression |
EXP |
bromobenzene results in increased expression of MEX3B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:136,855,130...136,859,365
|
|
G |
Mfsd2a |
MFSD2 lysolipid transporter A, lysophospholipid |
increases expression |
EXP |
bromobenzene results in increased expression of MFSD2A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:140,510,933...140,525,828
|
|
G |
Mgat4b |
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B |
decreases expression |
EXP |
bromobenzene results in decreased expression of MGAT4B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:34,548,918...34,559,229
|
|
G |
Mid1ip1 |
MID1 interacting protein 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MID1IP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:12,060,993...12,063,318
|
|
G |
Mif |
macrophage migration inhibitory factor |
affects binding |
EXP |
bromobenzene metabolite binds to MIF protein |
CTD |
PMID:17305373 |
|
NCBI chr20:12,790,919...12,791,784
|
|
G |
Mipol1 |
mirror-image polydactyly 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MIPOL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:74,755,293...75,090,403
|
|
G |
Mknk2 |
MAPK interacting serine/threonine kinase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MKNK2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:9,690,385...9,701,527
|
|
G |
Mmd2 |
monocyte to macrophage differentiation-associated 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MMD2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:17,075,870...17,123,255
|
|
G |
Mocos |
molybdenum cofactor sulfurase |
increases expression |
EXP |
bromobenzene results in increased expression of MOCOS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:15,931,659...15,977,415
|
|
G |
Mprip |
myosin phosphatase Rho interacting protein |
increases expression |
EXP |
bromobenzene results in increased expression of MPRIP mRNA |
CTD |
PMID:15056800 |
|
NCBI chr10:44,953,472...45,073,388
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MRC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:82,157,725...82,239,411
|
|
G |
Mroh9 |
maestro heat-like repeat family member 9 |
increases expression |
EXP |
bromobenzene results in increased expression of MROH9 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:75,387,800...75,443,118
|
|
G |
Ms4a1 |
membrane spanning 4-domains A1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MS4A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:207,906,370...207,927,028
|
|
G |
Ms4a6bl1 |
membrane-spanning 4-domains, subfamily A, member 6B-like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MS4A6BL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:208,243,561...208,255,400
|
|
G |
Msantd1 |
Myb/SANT DNA binding domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MSANTD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:75,832,368...75,845,687
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MSMO1 mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr16:24,980,680...24,997,927
|
|
G |
Mst1r |
macrophage stimulating 1 receptor |
decreases expression |
EXP |
bromobenzene results in decreased expression of MST1R mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:117,471,928...117,491,059
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:10,831,959...10,832,975
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
EXP |
bromobenzene results in increased expression of MT2A mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr19:10,837,934...10,838,708
|
|
G |
Mt4 |
metallothionein 4 |
increases expression |
EXP |
bromobenzene results in increased expression of MT4 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr19:10,863,813...10,865,909
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
increases expression |
EXP |
bromobenzene results in increased expression of MTHFD2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:115,811,135...115,822,663
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
decreases expression |
EXP |
bromobenzene results in decreased expression of MTHFR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:163,748,346...163,768,141
|
|
G |
Mtss1 |
MTSS I-BAR domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MTSS1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:90,488,751...90,628,007
|
|
G |
Muc13 |
mucin 13, cell surface associated |
decreases expression |
EXP |
bromobenzene results in decreased expression of MUC13 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:66,957,208...66,980,264
|
|
G |
Mug1 |
murinoglobulin 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MUG1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 4:155,076,270...155,130,051
|
|
G |
Mug2 |
murinoglobulin 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PZP mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 4:155,164,061...155,236,894
|
|
G |
Mvd |
mevalonate diphosphate decarboxylase |
decreases expression |
EXP |
bromobenzene results in decreased expression of MVD mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:50,496,366...50,506,429
|
|
G |
Mvk |
mevalonate kinase |
decreases expression |
EXP |
bromobenzene results in decreased expression of MVK mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:47,802,002...47,819,503
|
|
G |
Mx1 |
MX dynamin like GTPase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MX1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:36,799,659...36,825,209
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MYBL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:9,582,905...9,618,179
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
EXP |
bromobenzene results in increased expression of MYC mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:95,483,105...95,488,031
|
|
G |
Myh7b |
myosin heavy chain 7B |
increases expression |
EXP |
bromobenzene results in increased expression of MYH7B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:144,076,911...144,122,714
|
|
G |
Mylk3 |
myosin light chain kinase 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MYLK3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:37,858,298...37,916,805
|
|
G |
Myo9b |
myosin IXb |
decreases expression |
EXP |
bromobenzene results in decreased expression of MYO9B mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr16:17,945,379...18,030,114
|
|
G |
Myom2 |
myomesin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of MYOM2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:74,520,148...74,592,658
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
increases expression |
EXP |
bromobenzene results in increased expression of NAMPT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:55,152,756...55,189,547
|
|
G |
Nat8f5 |
N-acetyltransferase 8 (GCN5-related) family member 5 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NAT8F5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:118,260,323...118,285,038
|
|
G |
Ncald |
neurocalcin delta |
increases expression |
EXP |
bromobenzene results in increased expression of NCALD mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:68,532,671...68,964,740
|
|
G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of NCEH1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:112,003,677...112,064,274
|
|
G |
Ndst1 |
N-deacetylase and N-sulfotransferase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NDST1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:54,136,887...54,199,545
|
|
G |
Neil2 |
nei-like DNA glycosylase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of NEIL2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:37,444,676...37,454,863
|
|
G |
Nes |
nestin |
increases expression |
EXP |
bromobenzene results in increased expression of NES mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:175,735,715...175,745,631
|
|
G |
Nfe2 |
nuclear factor, erythroid 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NFE2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:134,382,758...134,395,364
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases localization increases expression |
ISO |
bromobenzene results in increased localization of NFE2L2 protein bromobenzene analog results in increased expression of NFE2L2 protein |
CTD |
PMID:18078705 PMID:19427879 |
|
NCBI chr 3:81,001,529...81,031,165
|
|
G |
Nherf1 |
NHERF family PDZ scaffold protein 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NHERF1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:100,403,189...100,420,290
|
|
G |
Nim1k |
NIM1 serine/threonine protein kinase |
increases expression |
EXP |
bromobenzene results in increased expression of NIM1K mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:53,403,467...53,451,248
|
|
G |
Nkx1-2 |
NK1 homeobox 2 |
increases expression |
EXP |
bromobenzene results in increased expression of NKX1-2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:187,386,370...187,391,252
|
|
G |
Nmrk2 |
nicotinamide riboside kinase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of NMRK2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:9,165,567...9,168,638
|
|
G |
Noct |
nocturnin |
increases expression |
EXP |
bromobenzene results in increased expression of NOCT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:137,422,074...137,442,282
|
|
G |
Nol8 |
nucleolar protein 8 |
increases expression |
EXP |
bromobenzene results in increased expression of NOL8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:14,990,394...15,013,784
|
|
G |
Nox4 |
NADPH oxidase 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NOX4 mRNA |
CTD |
PMID:15976192 |
|
NCBI chr 1:150,313,736...150,491,480
|
|
G |
Npas2 |
neuronal PAS domain protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of NPAS2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:41,463,361...41,642,322
|
|
G |
Npm1 |
nucleophosmin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of NPM1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:17,741,512...17,751,626
|
|
G |
Npr3 |
natriuretic peptide receptor 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NPR3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:60,865,483...60,933,432
|
|
G |
Npsr1 |
neuropeptide S receptor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NPSR1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:30,882,830...31,107,425
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
affects response to substance increases expression |
ISO EXP |
NQO1 protein affects the susceptibility to bromobenzene bromobenzene results in increased expression of NQO1 mRNA |
CTD |
PMID:10092053 PMID:15976192 PMID:17538237 PMID:32479839 |
|
NCBI chr19:52,205,374...52,220,267
|
|
G |
Nrbf2 |
nuclear receptor binding factor 2 |
increases expression |
EXP |
bromobenzene results in increased expression of NRBF2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:21,308,555...21,326,881
|
|
G |
Nrep |
neuronal regeneration related protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of NREP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:25,291,219...25,320,742
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of NTRK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:175,534,844...175,551,664
|
|
G |
Nudt4 |
nudix hydrolase 4 |
increases expression |
EXP |
bromobenzene results in increased expression of NUDT4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:32,074,978...32,091,491
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
decreases expression |
EXP |
bromobenzene results in decreased expression of NUPR1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 1:190,643,866...190,645,901
|
|
G |
Nxph3 |
neurexophilin 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NXPH3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:80,953,080...80,956,746
|
|
G |
Odf2l |
outer dense fiber of sperm tails 2-like |
increases expression |
EXP |
bromobenzene results in increased expression of ODF2L mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:234,036,049...234,072,751
|
|
G |
Olr35 |
olfactory receptor 35 |
increases expression |
EXP |
bromobenzene results in increased expression of OLR35 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:153,994,678...154,043,281
|
|
G |
Omd |
osteomodulin |
increases expression |
EXP |
bromobenzene results in increased expression of OMD mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:15,060,217...15,068,441
|
|
G |
Orc1 |
origin recognition complex, subunit 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ORC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:128,552,975...128,581,943
|
|
G |
Orm1 |
orosomucoid 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ORM1 mRNA |
CTD |
PMID:16036859 |
|
NCBI chr 5:81,788,509...81,791,661
|
|
G |
Osbp2 |
oxysterol binding protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of OSBP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:82,808,693...82,970,386
|
|
G |
Osbpl8 |
oxysterol binding protein-like 8 |
decreases expression |
EXP |
bromobenzene results in decreased expression of OSBPL8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:46,596,944...46,749,888
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
increases expression |
EXP |
bromobenzene results in increased expression of OSGIN1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:47,471,750...47,500,517
|
|
G |
Otud6b |
OTU deubiquitinase 6B |
increases expression |
EXP |
bromobenzene results in increased expression of OTUD6B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:28,181,992...28,214,486
|
|
G |
Oxct1 |
3-oxoacid CoA transferase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of OXCT1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 2:54,963,964...55,112,303
|
|
G |
P2ry12 |
purinergic receptor P2Y12 |
increases expression |
EXP |
bromobenzene results in increased expression of P2RY12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:143,481,468...143,523,340
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
affects binding |
EXP |
bromobenzene metabolite binds to P4HB protein |
CTD |
PMID:12018992 |
|
NCBI chr10:105,836,972...105,848,583
|
|
G |
Padi1 |
peptidyl arginine deiminase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PADI1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:153,119,566...153,152,034
|
|
G |
Park7 |
Parkinsonism associated deglycase |
affects binding |
EXP |
bromobenzene metabolite binds to PARK7 protein |
CTD |
PMID:17305373 |
|
NCBI chr 5:166,636,551...166,659,825
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PARP14 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:78,408,134...78,440,201
|
|
G |
Pax3 |
paired box 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PAX3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:79,567,455...79,664,042
|
|
G |
Pax8 |
paired box 8 |
increases expression |
EXP |
bromobenzene results in increased expression of PAX8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:27,584,000...27,641,094
|
|
G |
Pcdh8 |
protocadherin 8 |
increases expression |
EXP |
bromobenzene results in increased expression of PCDH8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:55,198,470...55,203,039
|
|
G |
Pcdhb3 |
protocadherin beta 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PCDHB3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:29,011,667...29,014,221
|
|
G |
Pcp4 |
Purkinje cell protein 4 |
increases expression |
EXP |
bromobenzene results in increased expression of PCP4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:35,759,711...35,861,725
|
|
G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PCSK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:4,395,543...4,442,434
|
|
G |
Pcsk9 |
proprotein convertase subtilisin/kexin type 9 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PCSK9 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:126,440,102...126,462,507
|
|
G |
Pcyt1a |
phosphate cytidylyltransferase 1A, choline |
increases expression |
EXP |
bromobenzene results in increased expression of PCYT1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:68,313,860...68,357,828
|
|
G |
Pde6c |
phosphodiesterase 6C |
decreases expression |
EXP |
bromobenzene results in decreased expression of PDE6C mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:235,909,583...235,965,435
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
increases expression |
EXP |
bromobenzene results in increased expression of PDGFRB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:56,770,348...56,809,228
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
affects binding |
EXP |
bromobenzene metabolite binds to PDIA3 protein |
CTD |
PMID:12018992 |
|
NCBI chr 3:128,841,781...128,865,733
|
|
G |
Pdia5 |
protein disulfide isomerase family A, member 5 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PDIA5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:65,272,152...65,359,087
|
|
G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
affects binding |
EXP |
bromobenzene metabolite binds to PDIA6 protein |
CTD |
PMID:12018992 |
|
NCBI chr 6:45,791,704...45,808,947
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
increases expression |
EXP |
bromobenzene results in increased expression of PDK4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:34,558,327...34,568,329
|
|
G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
affects binding |
EXP |
bromobenzene metabolite binds to PEBP1 protein |
CTD |
PMID:17305373 |
|
NCBI chr12:44,946,307...44,967,890
|
|
G |
Per1 |
period circadian regulator 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PER1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:54,299,002...54,313,804
|
|
G |
Per2 |
period circadian regulator 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PER2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:99,454,828...99,497,069
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
increases expression |
EXP |
bromobenzene results in increased expression of PEX11A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:143,089,410...143,096,491
|
|
G |
Pfkfb1 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PFKFB1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:22,936,038...22,989,691
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
affects binding |
EXP |
bromobenzene metabolite binds to PGK1 protein |
CTD |
PMID:17305373 |
|
NCBI chr X:75,336,988...75,352,962
|
|
G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PHLDA1 mRNA |
CTD |
PMID:15976192 |
|
NCBI chr 7:48,853,690...48,855,894
|
|
G |
Pigu |
phosphatidylinositol glycan anchor biosynthesis, class U |
increases expression |
EXP |
bromobenzene results in increased expression of PIGU mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:143,784,831...143,881,268
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PIK3R1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:34,612,946...34,697,660
|
|
G |
Pim3 |
Pim-3 proto-oncogene, serine/threonine kinase |
increases expression |
EXP |
bromobenzene results in increased expression of PIM3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:121,822,076...121,836,257
|
|
G |
Pip4p2 |
phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of PIP4P2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:28,259,821...28,307,225
|
|
G |
Pir |
pirin |
increases expression |
EXP |
bromobenzene results in increased expression of PIR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:33,740,428...33,851,049
|
|
G |
Pklr |
pyruvate kinase L/R |
decreases expression |
EXP |
bromobenzene results in decreased expression of PKLR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:176,840,779...176,849,637
|
|
G |
Plekhm3 |
pleckstrin homology domain containing M3 |
increases expression |
EXP |
bromobenzene results in increased expression of PLEKHM3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:66,166,233...66,325,332
|
|
G |
Plin2 |
perilipin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of PLIN2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:106,202,634...106,258,748
|
|
G |
Plin5 |
perilipin 5 |
increases expression |
EXP |
bromobenzene results in increased expression of PLIN5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:939,745...946,188
|
|
G |
Plk3 |
polo-like kinase 3 |
increases expression |
EXP |
bromobenzene results in increased expression of PLK3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:135,843,725...135,848,900
|
|
G |
Plppr1 |
phospholipid phosphatase related 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PLPPR1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:63,437,457...63,725,286
|
|
G |
Plppr3 |
phospholipid phosphatase related 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PLPPR3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:9,831,162...9,842,434
|
|
G |
Pls1 |
plastin 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PLS1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:96,316,703...96,426,592
|
|
G |
Plxna2 |
plexin A2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PLXNA2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:106,163,103...106,358,979
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PNPLA3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:115,293,538...115,314,077
|
|
G |
Polg2 |
DNA polymerase gamma 2, accessory subunit |
increases expression |
EXP |
bromobenzene results in increased expression of POLG2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:91,712,586...91,723,008
|
|
G |
Polq |
DNA polymerase theta |
increases expression |
EXP |
bromobenzene results in increased expression of POLQ mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:77,179,190...77,281,270
|
|
G |
Por |
cytochrome p450 oxidoreductase |
increases expression |
EXP |
bromobenzene results in increased expression of POR mRNA |
CTD |
PMID:12628495 PMID:32479839 |
|
NCBI chr12:26,587,674...26,655,612
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases expression |
EXP |
bromobenzene results in increased expression of PPARGC1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:63,073,505...63,729,215
|
|
G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
increases expression |
EXP |
bromobenzene results in increased expression of PPAT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:31,215,741...31,250,144
|
|
G |
Ppcs |
phosphopantothenoylcysteine synthetase |
increases expression |
EXP |
bromobenzene results in increased expression of PPCS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:133,023,077...133,026,899
|
|
G |
Ppm1k |
protein phosphatase, Mg2+/Mn2+ dependent, 1K |
increases expression |
EXP |
bromobenzene results in increased expression of PPM1K mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:87,612,198...87,638,993
|
|
G |
Ppp1r3g |
protein phosphatase 1, regulatory subunit 3G |
increases expression |
EXP |
bromobenzene results in increased expression of PPP1R3G mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:28,874,956...28,878,288
|
|
G |
Ppp2r1b |
protein phosphatase 2 scaffold subunit A beta |
increases expression |
EXP |
bromobenzene results in increased expression of PPP2R1B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:60,092,540...60,125,512
|
|
G |
Pptc7 |
protein phosphatase targeting COQ7 |
increases expression |
EXP |
bromobenzene results in increased expression of PPTC7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:34,249,963...34,288,339
|
|
G |
Prdx6 |
peroxiredoxin 6 |
affects binding |
EXP |
bromobenzene metabolite binds to PRDX6 protein |
CTD |
PMID:17305373 |
|
NCBI chr13:73,528,746...73,539,295
|
|
G |
Prickle1 |
prickle planar cell polarity protein 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PRICKLE1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:124,639,142...124,735,027
|
|
G |
Prima1 |
proline rich membrane anchor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PRIMA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:122,338,365...122,390,955
|
|
G |
Prkag3 |
protein kinase AMP-activated non-catalytic subunit gamma 3 |
increases expression |
EXP |
bromobenzene results in increased expression of PRKAG3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:83,744,385...83,753,629
|
|
G |
Prmt7 |
protein arginine methyltransferase 7 |
increases expression |
EXP |
bromobenzene results in increased expression of PRMT7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:34,110,724...34,161,531
|
|
G |
Prok1 |
prokineticin 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PROK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:194,850,539...194,859,343
|
|
G |
Prpf3 |
pre-mRNA processing factor 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PRPF3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:183,379,041...183,403,526
|
|
G |
Prr30 |
proline rich 30 |
increases expression |
EXP |
bromobenzene results in increased expression of PRR30 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:25,415,069...25,417,582
|
|
G |
Prrg4 |
proline rich and Gla domain 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PRRG4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:111,669,508...111,698,205
|
|
G |
Prtfdc1 |
phosphoribosyl transferase domain containing 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PRTFDC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:88,457,872...88,563,109
|
|
G |
Psma1 |
proteasome 20S subunit alpha 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMA1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:168,442,421...168,453,440
|
|
G |
Psma3 |
proteasome 20S subunit alpha 3 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMA3 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 6:95,219,714...95,239,745
|
|
G |
Psmb3 |
proteasome 20S subunit beta 3 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMB3 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:83,193,787...83,200,883
|
|
G |
Psmb5 |
proteasome 20S subunit beta 5 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMB5 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr15:32,042,784...32,047,379
|
|
G |
Psmc3 |
proteasome 26S subunit, ATPase 3 |
affects binding |
EXP |
bromobenzene metabolite binds to PSMC3 protein |
CTD |
PMID:17305373 |
|
NCBI chr 3:77,031,825...77,037,207
|
|
G |
Psmc4 |
proteasome 26S subunit, ATPase 4 |
affects binding |
EXP |
bromobenzene metabolite binds to PSMC4 protein |
CTD |
PMID:17305373 |
|
NCBI chr 1:92,476,690...92,485,268
|
|
G |
Psmc5 |
proteasome 26S subunit, ATPase 5 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMC5 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:91,187,763...91,193,697
|
|
G |
Psmd5 |
proteasome 26S subunit, non-ATPase 5 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMD5 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 3:18,133,715...18,151,000
|
|
G |
Psme1 |
proteasome activator subunit 1 |
affects binding |
EXP |
bromobenzene metabolite binds to PSME1 protein |
CTD |
PMID:17305373 |
|
NCBI chr15:29,069,012...29,071,888
|
|
G |
Ptgds |
prostaglandin D2 synthase |
increases expression |
EXP |
bromobenzene results in increased expression of PTGDS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:28,680,044...28,682,978
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[bromobenzene co-treated with EGLN1 mutant form] results in increased expression of PTGS2 mRNA |
CTD |
PMID:24190904 |
|
NCBI chr13:64,714,063...64,722,320
|
|
G |
Ptma |
prothymosin alpha |
increases expression |
EXP |
bromobenzene results in increased expression of PTMA mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 9:94,624,194...94,628,276
|
|
G |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
increases expression |
EXP |
bromobenzene results in increased expression of PTPN14 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:103,799,473...103,951,708
|
|
G |
Ptprcap |
protein tyrosine phosphatase, receptor type, C-associated protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of PTPRCAP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:201,449,133...201,451,293
|
|
G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
increases expression |
EXP |
bromobenzene results in increased expression of PTPRG mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:12,871,706...13,552,186
|
|
G |
Ptpru |
protein tyrosine phosphatase, receptor type, U |
increases expression |
EXP |
bromobenzene results in increased expression of PTPRU mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:143,950,542...144,024,791
|
|
G |
Pvr |
PVR cell adhesion molecule |
increases expression |
EXP |
bromobenzene results in increased expression of PVR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:79,561,294...79,576,700
|
|
G |
Pygm |
glycogen phosphorylase, muscle associated |
decreases expression |
EXP |
bromobenzene results in decreased expression of PYGM mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:203,690,550...203,705,369
|
|
G |
Qrfpr |
pyroglutamylated RFamide peptide receptor |
increases expression |
EXP |
bromobenzene results in increased expression of QRFPR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:119,053,083...119,096,864
|
|
G |
Rab23 |
RAB23, member RAS oncogene family |
increases expression |
EXP |
bromobenzene results in increased expression of RAB23 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:35,943,522...35,967,367
|
|
G |
Rab30 |
RAB30, member RAS oncogene family |
increases expression |
EXP |
bromobenzene results in increased expression of RAB30 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:156,216,137...156,310,778
|
|
G |
Rab9b |
RAB9B, member RAS oncogene family |
decreases expression |
EXP |
bromobenzene results in decreased expression of RAB9B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:100,220,897...100,231,591
|
|
G |
Rad51 |
RAD51 recombinase |
decreases expression |
EXP |
bromobenzene results in decreased expression of RAD51 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:126,554,210...126,578,888
|
|
G |
Rad54l2 |
RAD54 like 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of RAD54L2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:107,324,945...107,427,033
|
|
G |
Ran |
RAN, member RAS oncogene family |
increases expression |
EXP |
bromobenzene results in increased expression of RAN mRNA |
CTD |
PMID:12628495 |
|
NCBI chr12:27,674,049...27,678,598
|
|
G |
Rasd1 |
ras related dexamethasone induced 1 |
increases expression |
EXP |
bromobenzene results in increased expression of RASD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:45,265,975...45,275,279
|
|
G |
Rasl10a |
RAS-like, family 10, member A |
decreases expression |
EXP |
bromobenzene results in decreased expression of RASL10A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:79,955,093...79,956,471
|
|
G |
Rec8 |
REC8 meiotic recombination protein |
increases expression |
EXP |
bromobenzene results in increased expression of REC8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:29,109,862...29,117,327
|
|
G |
Reg4 |
regenerating family member 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of REG4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:185,818,946...185,833,252
|
|
G |
RGD1562699 |
RGD1562699 |
decreases expression |
EXP |
bromobenzene results in decreased expression of RGD1562699 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:57,826,815...57,831,464
|
|
G |
Rgma |
repulsive guidance molecule BMP co-receptor a |
increases expression |
EXP |
bromobenzene results in increased expression of RGMA mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:127,128,934...127,172,918
|
|
G |
Rgn |
regucalcin |
affects binding |
EXP |
bromobenzene metabolite binds to RGN protein |
CTD |
PMID:17305373 |
|
NCBI chr X:1,619,030...1,634,456
|
|
G |
Rgs1 |
regulator of G-protein signaling 1 |
increases expression |
EXP |
bromobenzene results in increased expression of RGS1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:58,568,844...58,573,187
|
|
G |
Rgs20 |
regulator of G-protein signaling 20 |
increases expression |
EXP |
bromobenzene results in increased expression of RGS20 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:14,484,436...14,614,317
|
|
G |
Rgs3 |
regulator of G-protein signaling 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of RGS3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:76,022,038...76,161,895
|
|
G |
Rgs9bp |
regulator of G protein signaling 9 binding protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of RGS9BP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:97,386,326...97,387,039
|
|
G |
Rhbdd2 |
rhomboid domain containing 2 |
increases expression |
EXP |
bromobenzene results in increased expression of RHBDD2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:21,043,605...21,054,305
|
|
G |
Rida |
reactive intermediate imine deaminase A homolog |
affects binding |
EXP |
bromobenzene metabolite binds to RIDA protein |
CTD |
PMID:17305373 |
|
NCBI chr 7:65,691,429...65,705,257
|
|
G |
Rlim |
ring finger protein, LIM domain interacting |
increases expression |
EXP |
bromobenzene results in increased expression of RLIM mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:68,983,259...69,004,368
|
|
G |
Rnase11 |
ribonuclease A family member 11 |
affects expression |
EXP |
bromobenzene affects the expression of RNASE11 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:24,268,206...24,270,192
|
|
G |
Rnf151 |
ring finger protein 151 |
increases expression |
EXP |
bromobenzene results in increased expression of RNF151 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:13,742,682...13,747,192
|
|
G |
Ropn1 |
rhophilin associated tail protein 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ROPN1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:66,097,854...66,127,148
|
|
G |
Rpl15 |
ribosomal protein L15 |
increases expression |
EXP |
bromobenzene results in increased expression of RPL15 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr15:9,934,663...9,937,946
|
|
G |
Rpl22 |
ribosomal protein L22 |
increases expression |
EXP |
bromobenzene results in increased expression of RPL22 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 5:162,835,241...162,843,394
|
|
G |
Rpl27a |
ribosomal protein L27A |
increases expression |
EXP |
bromobenzene results in increased expression of RPL27A mRNA |
CTD |
PMID:16036859 |
|
NCBI chr 1:163,539,732...163,542,771
|
|
G |
Rpl35 |
ribosomal protein L35 |
increases expression decreases expression |
EXP |
bromobenzene results in increased expression of RPL35 mRNA bromobenzene results in decreased expression of RPL35 mRNA |
CTD |
PMID:12628495 PMID:15056800 |
|
NCBI chr 3:22,753,255...22,756,217
|
|
G |
Rpl6 |
ribosomal protein L6 |
increases expression |
EXP |
bromobenzene results in increased expression of RPL6 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr12:41,008,142...41,012,756
|
|
G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator homolog |
increases expression |
EXP |
bromobenzene results in increased expression of RPRM mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:58,948,618...58,950,035
|
|
G |
Rps11 |
ribosomal protein S11 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS11 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:104,742,153...104,744,261
|
|
G |
Rps2 |
ribosomal protein S2 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:14,251,841...14,253,697
|
|
G |
Rps26 |
ribosomal protein S26 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS26 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 7:1,057,332...1,058,882
|
|
G |
Rps26l1 |
ribosomal protein S26 like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS26L1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:62,981,687...62,982,757
|
|
G |
Rps3a |
ribosomal protein S3a |
increases expression |
EXP |
bromobenzene results in increased expression of RPS3A mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:171,524,685...171,529,054
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS6KB1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr10:71,817,794...71,865,211
|
|
G |
Rps8 |
ribosomal protein S8 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS8 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 5:130,630,362...130,632,932
|
|
G |
Rrp9 |
ribosomal RNA processing 9, U3 small nucleolar RNA binding protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of RRP9 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 8:115,995,119...116,004,832
|
|
G |
Rsrp1 |
arginine and serine rich protein 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of RSRP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:152,431,448...152,435,202
|
|
G |
RT1-CE10 |
RT1 class I, locus CE10 |
increases expression |
EXP |
bromobenzene results in increased expression of RT1-CE10 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:3,377,284...3,380,301
|
|
G |
RT1-CE3 |
RT1 class I, locus CE3 |
increases expression |
EXP |
bromobenzene results in increased expression of RT1-CE3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:3,516,647...3,520,938
|
|
G |
RT1-M2 |
RT1 class Ib, locus M2 |
increases expression |
EXP |
bromobenzene results in increased expression of RT1-M2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:978,918...981,510
|
|
G |
RT1-M6-2 |
RT1 class I, locus M6, gene 2 |
increases expression |
EXP |
bromobenzene results in increased expression of RT1-M6-2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:1,583,267...1,587,099
|
|
G |
RT1-N1 |
RT1 class Ib, locus N1 |
increases expression decreases expression |
EXP |
bromobenzene results in increased expression of RT1-N1 mRNA bromobenzene results in decreased expression of RT1-N1 mRNA |
CTD |
PMID:12628495 PMID:15056800 |
|
|
|
G |
RT1-S2 |
RT1 class Ib, locus S2 |
increases expression |
EXP |
bromobenzene results in increased expression of RT1-S2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:2,650,233...2,651,654
|
|
G |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of RTN4RL2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:69,954,557...69,971,108
|
|
G |
Sacs |
sacsin molecular chaperone |
increases expression |
EXP |
bromobenzene results in increased expression of SACS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:35,285,783...35,370,335
|
|
G |
Samd4a |
sterile alpha motif domain containing 4A |
increases expression |
EXP |
bromobenzene results in increased expression of SAMD4A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:22,616,200...22,831,872
|
|
G |
Sapcd2 |
suppressor APC domain containing 2 |
increases expression |
EXP |
bromobenzene results in increased expression of SAPCD2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:28,583,615...28,590,694
|
|
G |
Sash1 |
SAM and SH3 domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SASH1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:3,119,915...3,418,536
|
|
G |
Saxo2 |
stabilizer of axonemal microtubules 2 |
increases expression |
EXP |
bromobenzene results in increased expression of SAXO2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:136,596,445...136,638,444
|
|
G |
Sbds |
Sbds, ribosome maturation factor |
decreases expression |
EXP |
bromobenzene results in decreased expression of SBDS mRNA |
CTD |
PMID:12628495 |
|
NCBI chr12:26,420,410...26,429,650
|
|
G |
Sc5d |
sterol-C5-desaturase |
decreases expression |
EXP |
bromobenzene results in decreased expression of SC5D mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:42,629,649...42,641,257
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression increases expression |
EXP |
bromobenzene results in decreased expression of SCD1 mRNA bromobenzene results in increased expression of SCD mRNA |
CTD |
PMID:15976192 PMID:32479839 |
|
NCBI chr 1:253,218,968...253,232,101
|
|
G |
Scn4b |
sodium voltage-gated channel beta subunit 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SCN4B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:54,343,873...54,359,046
|
|
G |
Scnn1a |
sodium channel epithelial 1 subunit alpha |
increases expression |
EXP |
bromobenzene results in increased expression of SCNN1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:158,122,962...158,146,184
|
|
G |
Sdc4 |
syndecan 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SDC4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:153,154,888...153,173,576
|
|
G |
Sds |
serine dehydratase |
increases expression |
EXP |
bromobenzene results in increased expression of SDS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:36,083,226...36,090,540
|
|
G |
Sebox |
SEBOX homeobox |
decreases expression |
EXP |
bromobenzene results in decreased expression of SEBOX mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:63,399,215...63,400,086
|
|
G |
Selenbp1 |
selenium binding protein 1 |
affects binding |
EXP |
bromobenzene metabolite binds to SELENBP1 protein |
CTD |
PMID:17305373 |
|
NCBI chr 2:182,494,004...182,504,594
|
|
G |
Selenop |
selenoprotein P |
decreases expression |
EXP |
bromobenzene results in decreased expression of SELENOP mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:52,498,123...52,508,409
|
|
G |
Sell |
selectin L |
decreases expression |
EXP |
bromobenzene results in decreased expression of SELL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:78,950,100...78,969,604
|
|
G |
Sema6b |
semaphorin 6B |
increases expression |
EXP |
bromobenzene results in increased expression of SEMA6B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:950,939...967,905
|
|
G |
Sesn2 |
sestrin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of SESN2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:149,986,304...150,005,255
|
|
G |
Setbp1 |
SET binding protein 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SETBP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:74,465,616...74,827,455
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SGK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:24,799,391...24,916,886
|
|
G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SGK2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:172,063,625...172,089,000
|
|
G |
Sh2d4a |
SH2 domain containing 4A |
decreases expression |
EXP |
bromobenzene results in decreased expression of SH2D4A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:21,339,010...21,409,360
|
|
G |
Sh3pxd2b |
SH3 and PX domains 2B |
increases expression |
EXP |
bromobenzene results in increased expression of SH3PXD2B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:17,422,906...17,538,977
|
|
G |
Sidt1 |
SID1 transmembrane family, member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SIDT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:56,362,788...56,459,939
|
|
G |
Slamf6 |
SLAM family member 6 |
increases expression |
EXP |
bromobenzene results in increased expression of SLAMF6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:84,384,561...84,405,300
|
|
G |
Slc10a2 |
solute carrier family 10 member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC10A2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:91,088,089...91,111,025
|
|
G |
Slc10a6 |
solute carrier family 10 member 6 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC10A6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:6,080,716...6,102,902
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC11A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:75,957,193...75,968,115
|
|
G |
Slc13a2 |
solute carrier family 13 member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC13A2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:63,291,813...63,319,127
|
|
G |
Slc13a4 |
solute carrier family 13 member 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC13A4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:63,943,369...63,988,852
|
|
G |
Slc13a5 |
solute carrier family 13 member 5 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC13A5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:56,866,249...56,891,189
|
|
G |
Slc15a4 |
solute carrier family 15 member 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC15A4 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr12:34,684,583...34,718,429
|
|
G |
Slc16a5 |
solute carrier family 16 member 5 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC16A5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:100,707,434...100,721,338
|
|
G |
Slc17a9 |
solute carrier family 17 member 9 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC17A9 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:188,211,106...188,233,553
|
|
G |
Slc19a2 |
solute carrier family 19 member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC19A2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:79,135,118...79,149,316
|
|
G |
Slc1a3 |
solute carrier family 1 member 3 |
affects expression |
EXP |
bromobenzene affects the expression of SLC1A3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:57,755,495...57,830,605
|
|
G |
Slc1a4 |
solute carrier family 1 member 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC1A4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:98,718,646...98,761,672
|
|
G |
Slc22a5 |
solute carrier family 22 member 5 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC22A5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:38,008,303...38,035,474
|
|
G |
Slc25a15 |
solute carrier family 25 member 15 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC25A15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:69,631,581...69,654,869
|
|
G |
Slc25a25 |
solute carrier family 25 member 25 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC25A25 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:15,708,702...15,742,195
|
|
G |
Slc25a27 |
solute carrier family 25, member 27 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC25A27 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:17,306,898...17,333,942
|
|
G |
Slc25a29 |
solute carrier family 25 member 29 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC25A29 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:127,742,027...127,752,915
|
|
G |
Slc25a30 |
solute carrier family 25, member 30 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC25A30 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:51,076,998...51,099,613
|
|
G |
Slc25a32 |
solute carrier family 25 member 32 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC25A32 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:70,142,958...70,160,726
|
|
G |
Slc29a4 |
solute carrier family 29 member 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC29A4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:11,853,540...11,884,660
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC2A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:138,002,522...138,030,742
|
|
G |
Slc34a2 |
solute carrier family 34 member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC34A2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:57,910,931...57,930,236
|
|
G |
Slc35g1 |
solute carrier family 35, member G1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC35G1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:236,163,593...236,172,115
|
|
G |
Slc38a2 |
solute carrier family 38, member 2 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC38A2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:129,730,450...129,742,619
|
|
G |
Slc43a1 |
solute carrier family 43 member 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC43A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:69,920,586...69,946,768
|
|
G |
Slc44a3 |
solute carrier family 44, member 3 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC44A3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:209,552,138...209,628,182
|
|
G |
Slc45a3 |
solute carrier family 45, member 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC45A3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:43,407,293...43,427,588
|
|
G |
Slc4a11 |
solute carrier family 4 member 11 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC4A11 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:117,900,223...117,912,787
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC4A4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:19,125,394...19,577,379
|
|
G |
Slc4a5 |
solute carrier family 4 member 5 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC4A5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:115,710,101...115,810,330
|
|
G |
Slc51a |
solute carrier family 51 member A |
increases expression |
EXP |
bromobenzene results in increased expression of SLC51A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:68,299,086...68,313,485
|
|
G |
Slc5a8 |
solute carrier family 5 member 8 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC5A8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:23,272,891...23,313,811
|
|
G |
Slc6a14 |
solute carrier family 6 member 14 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC6A14 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:117,109,063...117,169,522
|
|
G |
Slc6a6 |
solute carrier family 6 member 6 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC6A6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:124,195,186...124,268,880
|
|
G |
Slc7a1 |
solute carrier family 7 member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC7A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:11,664,488...11,740,030
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC7A11 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:136,532,912...136,668,560
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLCO1A4 mRNA |
CTD |
PMID:15976192 PMID:32479839 |
|
NCBI chr 4:174,710,004...174,764,810
|
|
G |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLCO1C1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:174,466,621...174,513,290
|
|
G |
Slit1 |
slit guidance ligand 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLIT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:240,409,559...240,558,127
|
|
G |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLITRK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:85,723,252...85,727,290
|
|
G |
Smox |
spermine oxidase |
increases expression |
EXP |
bromobenzene results in increased expression of SMOX mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:118,731,814...118,767,242
|
|
G |
Sntb1 |
syntrophin, beta 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SNTB1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:88,950,642...89,219,017
|
|
G |
Sod1 |
superoxide dismutase 1 |
affects binding |
EXP |
bromobenzene metabolite binds to SOD1 protein |
CTD |
PMID:17305373 |
|
NCBI chr11:42,942,742...42,948,399
|
|
G |
Sord |
sorbitol dehydrogenase |
increases activity |
EXP |
bromobenzene results in increased activity of SORD protein |
CTD |
PMID:3012827 |
|
NCBI chr 3:109,184,697...109,216,133
|
|
G |
Spdya |
speedy/RINGO cell cycle regulator family member A |
decreases expression |
EXP |
bromobenzene results in decreased expression of SPDYA mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:23,905,574...23,954,926
|
|
G |
Spib |
Spi-B transcription factor |
decreases expression |
EXP |
bromobenzene results in decreased expression of SPIB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:95,018,939...95,024,804
|
|
G |
Spring1 |
SREBF pathway regulator in golgi 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SPRING1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:38,306,227...38,329,175
|
|
G |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SPSB1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:160,358,292...160,418,541
|
|
G |
Spsb4 |
splA/ryanodine receptor domain and SOCS box containing 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SPSB4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:97,536,519...97,609,757
|
|
G |
Sqle |
squalene epoxidase |
decreases expression |
EXP |
bromobenzene results in decreased expression of SQLE mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:90,867,973...90,883,623
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SREBF1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:45,507,152...45,529,164
|
|
G |
Srp68 |
signal recognition particle 68 |
increases expression |
EXP |
bromobenzene results in increased expression of SRP68 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:101,481,213...101,508,035
|
|
G |
Sstr3 |
somatostatin receptor 3 |
increases expression |
EXP |
bromobenzene results in increased expression of SSTR3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:110,092,563...110,109,043
|
|
G |
St8sia1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ST8SIA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:175,782,989...175,921,338
|
|
G |
Stac3 |
SH3 and cysteine rich domain 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of STAC3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:63,343,078...63,350,590
|
|
G |
Stard4 |
StAR-related lipid transfer domain containing 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of STARD4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:24,814,683...24,830,024
|
|
G |
Stc1 |
stanniocalcin 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of STC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:44,299,591...44,311,695
|
|
G |
Steap2 |
STEAP2 metalloreductase |
increases expression |
EXP |
bromobenzene results in increased expression of STEAP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:29,302,487...29,323,006
|
|
G |
Stoml3 |
stomatin like 3 |
increases expression |
EXP |
bromobenzene results in increased expression of STOML3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:137,572,691...137,582,402
|
|
G |
Stxbp5l |
syntaxin binding protein 5L |
increases expression |
EXP |
bromobenzene results in increased expression of STXBP5L mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:63,334,667...63,654,270
|
|
G |
Sult1b1 |
sulfotransferase family 1B member 1 |
affects binding |
EXP |
bromobenzene metabolite binds to SULT1B1 protein |
CTD |
PMID:17305373 |
|
NCBI chr14:20,492,763...20,505,491
|
|
G |
Sult1c3 |
sulfotransferase family 1C member 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SULT1C1 mRNA |
CTD |
PMID:15976192 |
|
NCBI chr 9:7,221,580...7,266,991
|
|
G |
Svop |
SV2 related protein |
increases expression |
EXP |
bromobenzene results in increased expression of SVOP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:42,530,991...42,589,381
|
|
G |
Synj2 |
synaptojanin 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SYNJ2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:46,518,594...46,621,919
|
|
G |
Synpr |
synaptoporin |
decreases expression |
EXP |
bromobenzene results in decreased expression of SYNPR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:11,573,373...11,900,255
|
|
G |
Sypl1 |
synaptophysin-like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SYPL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:49,565,111...49,585,205
|
|
G |
Syt2 |
synaptotagmin 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SYT2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:46,088,046...46,197,976
|
|
G |
Taf9b |
TATA-box binding protein associated factor 9b |
increases expression |
EXP |
bromobenzene results in increased expression of TAF9B mRNA |
CTD |
PMID:12628495 |
|
NCBI chr X:71,289,290...71,300,142
|
|
G |
Tanc1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of TANC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:44,099,387...44,335,478
|
|
G |
Tat |
tyrosine aminotransferase |
increases expression |
EXP |
bromobenzene results in increased expression of TAT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:37,947,153...37,957,717
|
|
G |
Tbx3 |
T-box transcription factor 3 |
increases expression |
EXP |
bromobenzene results in increased expression of TBX3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:42,540,378...42,555,490
|
|
G |
Tcea3 |
transcription elongation factor A3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TCEA3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:148,476,941...148,509,452
|
|
G |
Tcim |
transcriptional and immune response regulator |
increases expression |
EXP |
bromobenzene results in increased expression of TCIM mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:67,595,762...67,597,055
|
|
G |
Tdrd1 |
tudor domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of TDRD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:255,871,939...255,919,222
|
|
G |
Tekt4 |
tektin 4 |
increases expression |
EXP |
bromobenzene results in increased expression of TEKT4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:14,487,760...14,492,936
|
|
G |
Tenm2 |
teneurin transmembrane protein 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TENM2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:20,984,710...22,121,001
|
|
G |
Tex36 |
testis expressed 36 |
increases expression |
EXP |
bromobenzene results in increased expression of TEX36 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:188,390,062...188,404,448
|
|
G |
Tex52 |
testis expressed 52 |
increases expression |
EXP |
bromobenzene results in increased expression of TEX52 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:161,651,232...161,663,250
|
|
G |
Tf |
transferrin |
decreases expression |
EXP |
bromobenzene results in decreased expression of TF mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 8:103,789,780...103,816,487
|
|
G |
Tfcp2 |
transcription factor CP2 |
increases expression |
EXP |
bromobenzene results in increased expression of TFCP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:133,495,577...133,537,799
|
|
G |
Tg |
thyroglobulin |
decreases expression |
EXP |
bromobenzene results in decreased expression of TG mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:98,418,293...98,603,210
|
|
G |
Thbs4 |
thrombospondin 4 |
increases expression |
EXP |
bromobenzene results in increased expression of THBS4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:23,983,158...24,025,289
|
|
G |
Thra |
thyroid hormone receptor alpha |
decreases expression |
EXP |
bromobenzene results in decreased expression of THRA mRNA |
CTD |
PMID:15976192 |
|
NCBI chr10:84,198,141...84,225,659
|
|
G |
Thrsp |
thyroid hormone responsive |
decreases expression |
EXP |
bromobenzene results in decreased expression of THRSP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:161,134,640...161,138,964
|
|
G |
Thsd7b |
thrombospondin type 1 domain containing 7B |
increases expression |
EXP |
bromobenzene results in increased expression of THSD7B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:40,768,567...41,667,262
|
|
G |
Timeless |
timeless circadian regulator |
decreases expression |
EXP |
bromobenzene results in decreased expression of TIMELESS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:654,804...678,769
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
EXP |
bromobenzene results in increased expression of TIMP1 mRNA |
CTD |
PMID:12628495 PMID:15056800 |
|
NCBI chr X:3,766,509...3,772,578
|
|
G |
Tlr5 |
toll-like receptor 5 |
increases expression |
EXP |
bromobenzene results in increased expression of TLR5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:97,166,430...97,190,642
|
|
G |
Tmem179 |
transmembrane protein 179 |
increases expression |
EXP |
bromobenzene results in increased expression of TMEM179 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:131,569,289...131,580,413
|
|
G |
Tmem252 |
transmembrane protein 252 |
increases expression |
EXP |
bromobenzene results in increased expression of TMEM252 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:222,316,982...222,321,946
|
|
G |
Tmem26 |
transmembrane protein 26 |
increases expression |
EXP |
bromobenzene results in increased expression of TMEM26 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:19,820,768...19,872,561
|
|
G |
Tmem30b |
transmembrane protein 30B |
increases expression |
EXP |
bromobenzene results in increased expression of TMEM30B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:92,251,626...92,254,702
|
|
G |
Tmprss13 |
transmembrane serine protease 13 |
increases expression |
EXP |
bromobenzene results in increased expression of TMPRSS13 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:45,625,759...45,653,943
|
|
G |
Tmsb10 |
thymosin, beta 10 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TMSB10 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 4:106,568,080...106,569,210
|
|
G |
Tnfaip2 |
TNF alpha induced protein 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TNFAIP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:136,297,388...136,311,106
|
|
G |
Tnfaip8l3 |
TNF alpha induced protein 8 like 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TNFAIP8L3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:54,413,503...54,455,512
|
|
G |
Tnfrsf11a |
TNF receptor superfamily member 11A |
increases expression |
EXP |
bromobenzene results in increased expression of TNFRSF11A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:22,442,930...22,501,257
|
|
G |
Tnfrsf4 |
TNF receptor superfamily member 4 |
increases expression |
EXP |
bromobenzene results in increased expression of TNFRSF4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:171,889,134...171,891,824
|
|
G |
Tnnc2 |
troponin C2, fast skeletal type |
increases expression |
EXP |
bromobenzene results in increased expression of TNNC2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:153,513,272...153,516,033
|
|
G |
Tnrc6a |
trinucleotide repeat containing adaptor 6A |
increases expression |
EXP |
bromobenzene results in increased expression of TNRC6A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:186,992,457...187,146,764
|
|
G |
Togaram2 |
TOG array regulator of axonemal microtubules 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TOGARAM2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:23,770,979...23,828,884
|
|
G |
Tom1l2 |
target of myb1 like 2 membrane trafficking protein |
increases expression |
EXP |
bromobenzene results in increased expression of TOM1L2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:45,535,548...45,657,528
|
|
G |
Tonsl |
tonsoku-like, DNA repair protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of TONSL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:108,345,704...108,360,792
|
|
G |
Tor3a |
torsin family 3, member A |
increases expression |
EXP |
bromobenzene results in increased expression of TOR3A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:68,769,893...68,798,738
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
affects binding |
EXP |
bromobenzene metabolite binds to TPI1 protein |
CTD |
PMID:17305373 |
|
NCBI chr 4:159,301,558...159,305,088
|
|
G |
Tpm1 |
tropomyosin 1 |
affects binding |
EXP |
bromobenzene metabolite binds to TPM1 protein |
CTD |
PMID:17305373 |
|
NCBI chr 8:67,635,479...67,662,330
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
EXP |
bromobenzene results in increased expression of TRIB3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:161,269,939...161,275,533
|
|
G |
Trim15 |
tripartite motif containing 15 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TRIM15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:1,700,905...1,710,249
|
|
G |
Trim24 |
tripartite motif-containing 24 |
increases expression |
EXP |
bromobenzene results in increased expression of TRIM24 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:67,534,240...67,659,014
|
|
G |
Trim36 |
tripartite motif-containing 36 |
increases expression |
EXP |
bromobenzene results in increased expression of TRIM36 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:38,859,604...38,912,859
|
|
G |
Trim43a |
tripartite motif-containing 43A |
increases expression |
EXP |
bromobenzene results in increased expression of TRIM43A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:89,562,568...89,568,716
|
|
G |
Trim45 |
tripartite motif-containing 45 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TRIM45 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:191,038,355...191,047,826
|
|
G |
Trim47 |
tripartite motif-containing 47 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TRIM47 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:101,337,573...101,342,044
|
|
G |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TRPM3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:219,673,200...220,557,610
|
|
G |
Tsc22d1 |
TSC22 domain family, member 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TSC22D1 mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr15:58,159,612...58,260,244
|
|
G |
Tshr |
thyroid stimulating hormone receptor |
decreases expression increases expression |
EXP |
bromobenzene results in decreased expression of TSHR mRNA bromobenzene results in increased expression of TSHR mRNA |
CTD |
PMID:12628495 PMID:15976192 |
|
NCBI chr 6:116,072,321...116,206,009
|
|
G |
Tsku |
tsukushi, small leucine rich proteoglycan |
increases expression |
EXP |
bromobenzene results in increased expression of TSKU mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:152,660,259...152,671,682
|
|
G |
Ttr |
transthyretin |
affects binding |
EXP |
bromobenzene metabolite binds to TTR protein |
CTD |
PMID:12018992 |
|
NCBI chr18:11,941,791...11,951,008
|
|
G |
Tuba1a |
tubulin, alpha 1A |
increases expression |
EXP |
bromobenzene results in increased expression of TUBA1A mRNA |
CTD |
PMID:16036859 |
|
NCBI chr 7:131,992,151...131,996,850
|
|
G |
Tubb2a |
tubulin, beta 2A class IIa |
decreases expression |
EXP |
bromobenzene results in decreased expression of TUBB2A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:30,796,842...30,800,713
|
|
G |
Tubb2b |
tubulin, beta 2B class IIb |
decreases expression |
EXP |
bromobenzene results in decreased expression of TUBB2B mRNA |
CTD |
PMID:15056800 |
|
NCBI chr17:30,953,086...30,956,133
|
|
G |
Tubb4b |
tubulin, beta 4B class IVb |
increases expression |
EXP |
bromobenzene results in increased expression of TUBB4B mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 3:28,435,999...28,438,455
|
|
G |
Txn1 |
thioredoxin 1 |
affects binding |
EXP |
bromobenzene metabolite binds to TXN1 protein |
CTD |
PMID:17305373 |
|
NCBI chr 5:77,507,455...77,519,685
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of TXNRD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:22,717,620...22,802,553
|
|
G |
Ubd |
ubiquitin D |
decreases expression |
EXP |
bromobenzene results in decreased expression of UBD mRNA |
CTD |
PMID:15056800 |
|
NCBI chr20:1,385,487...1,387,438
|
|
G |
Ugdh |
UDP-glucose 6-dehydrogenase |
affects binding |
EXP |
bromobenzene metabolite binds to UGDH protein |
CTD |
PMID:17305373 |
|
NCBI chr14:43,202,480...43,226,002
|
|
G |
Upb1 |
beta-ureidopropionase 1 |
affects binding |
EXP |
bromobenzene metabolite binds to UPB1 protein |
CTD |
PMID:17305373 |
|
NCBI chr20:13,216,693...13,243,016
|
|
G |
Upp2 |
uridine phosphorylase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of UPP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:43,273,048...43,317,417
|
|
G |
Usp2 |
ubiquitin specific peptidase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of USP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:53,308,264...53,336,800
|
|
G |
Usp49 |
ubiquitin specific peptidase 49 |
increases expression |
EXP |
bromobenzene results in increased expression of USP49 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:20,803,177...20,867,681
|
|
G |
Vegfd |
vascular endothelial growth factor D |
increases expression |
EXP |
bromobenzene results in increased expression of VEGFD mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:30,073,122...30,108,413
|
|
G |
Vtn |
vitronectin |
decreases expression |
EXP |
bromobenzene results in decreased expression of VTN mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:63,394,732...63,397,812
|
|
G |
Wdr27 |
WD repeat domain 27 |
decreases expression |
EXP |
bromobenzene results in decreased expression of WDR27 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:55,832,240...55,950,457
|
|
G |
Wdr91 |
WD repeat domain 91 |
increases expression |
EXP |
bromobenzene results in increased expression of WDR91 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:63,554,364...63,591,733
|
|
G |
Wnt4 |
Wnt family member 4 |
increases expression |
EXP |
bromobenzene results in increased expression of WNT4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:154,797,245...154,818,565
|
|
G |
Wsb1 |
WD repeat and SOCS box-containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of WSB1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:64,700,752...64,717,038
|
|
G |
Xbp1 |
X-box binding protein 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of XBP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:84,604,623...84,609,707
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases expression |
EXP |
bromobenzene results in decreased expression of XIAP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:125,756,107...125,803,979
|
|
G |
Xpo7 |
exportin 7 |
increases expression |
EXP |
bromobenzene results in increased expression of XPO7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:52,151,743...52,237,729
|
|
G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta |
decreases expression |
EXP |
bromobenzene results in decreased expression of YWHAQ mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 6:46,664,358...46,694,875
|
|
G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
decreases expression |
EXP |
bromobenzene results in decreased expression of YWHAZ mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 7:69,826,404...69,848,702
|
|
G |
Zbp1 |
Z-DNA binding protein 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ZBP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:161,993,351...162,009,297
|
|
G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
decreases expression increases expression |
EXP |
bromobenzene results in decreased expression of ZBTB16 mRNA bromobenzene results in increased expression of ZBTB16 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:57,885,886...58,073,507
|
|
G |
Zbtb7c |
zinc finger and BTB domain containing 7C |
decreases expression |
EXP |
bromobenzene results in decreased expression of ZBTB7C mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:69,441,616...69,765,744
|
|
G |
Zbtb8b |
zinc finger and BTB domain containing 8b |
increases expression |
EXP |
bromobenzene results in increased expression of ZBTB8B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:141,765,925...141,781,619
|
|
G |
Zfand2a |
zinc finger AN1-type containing 2A |
increases expression |
EXP |
bromobenzene results in increased expression of ZFAND2A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:15,161,601...15,172,679
|
|
G |
Zfp136 |
zinc finger protein 136 |
increases expression |
EXP |
bromobenzene results in increased expression of ZFP136 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:609,472...618,190
|
|
G |
Zfp354a |
zinc finger protein 354A |
affects expression |
EXP |
bromobenzene affects the expression of ZFP354A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:35,396,242...35,408,069
|
|
G |
Zfp385a |
zinc finger protein 385A |
decreases expression |
EXP |
bromobenzene results in decreased expression of ZFP385A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:136,327,393...136,354,017
|
|
G |
Zfp385b |
zinc finger protein 385B |
decreases expression |
EXP |
bromobenzene results in decreased expression of ZFP385B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:62,355,182...62,640,417
|
|
G |
Zfp418 |
zinc finger protein 418 |
increases expression |
EXP |
bromobenzene results in increased expression of ZFP418 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:66,581,406...66,594,247
|
|
G |
Zfp647 |
zinc finger protein 647 |
increases expression |
EXP |
bromobenzene results in increased expression of ZFP647 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:108,632,248...108,649,264
|
|
G |
Zmynd8 |
zinc finger, MYND-type containing 8 |
increases expression |
EXP |
bromobenzene results in increased expression of ZMYND8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:174,948,162...175,061,382
|
|
G |
Zscan18 |
zinc finger and SCAN domain containing 18 |
increases expression |
EXP |
bromobenzene results in increased expression of ZSCAN18 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:73,332,883...73,349,846
|
|